{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:47:45Z","timestamp":1785912465530,"version":"3.56.0"},"reference-count":339,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Helmholtz-Zentrum Dresden - Rossendorf e.V."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite major advances in radiation delivery, clinical outcomes remain constrained by tumor biology rather than technology. Conventional radiobiology has relied on reductionist two-dimensional (2D) systems that fail to capture the spatial, mechanical, and multicellular organization of tumors. Three-dimensional (3D) tumor models now resolve radiation response as a mechanobiological process coordinated across the extracellular matrix (ECM), adhesion signaling, cytoskeleton, and nucleus. This review focuses on a specific and we argue, underappreciated intersection: how 3D models expose integrin-mediated mechanotransduction as a determinant of the DNA damage response (DDR) and therapy resistance epitomized by cell adhesion-mediated radioresistance (CAM-RR) - an organizing principle we frame as the ECM-integrin-nucleus axis. We first delineate which model classes resolve which layer of this biology, distinguishing effects of three-dimensional organization from those of defined ECM-integrin signaling, and we treat the underlying mechanobiology quantitatively rather than descriptively. We then develop a mechanistic framework linking ECM architecture and stiffness to integrin-RTK crosstalk, cytoskeletal tension, LINC-mediated force transfer, and chromatin-dependent DNA repair, in which radiosensitivity emerges as a property of tissue context. From a translational standpoint, 3D models enable functional, radiation-specific assessment of context-dependent radiosensitivity and of mechanically targeted radiosensitization, while their integration with quantitative imaging and computational approaches further supports biomarker-guided and adaptive treatment strategies. We close with testable predictions that this framework generates, intended to guide the next phase of biology-driven radiation oncology.<\/jats:p>","DOI":"10.1186\/s13046-026-03803-6","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:48:41Z","timestamp":1785901721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance"],"prefix":"10.1186","volume":"45","author":[{"given":"Nils","family":"Cordes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"5\u20136","key":"3803_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/02841860310011159","volume":"42","author":"H Svensson","year":"2003","unstructured":"Svensson H, M\u00f6ller TR, SBU Survey Group. Developments in radiotherapy. Acta Oncol. 2003;42(5\u20136):430\u201342. doi:10.1080\/02841860310011159 PubMed PMID: 14596505.","journal-title":"Acta Oncol"},{"key":"3803_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2021.06.018","volume":"84","author":"R Rosenquist","year":"2022","unstructured":"Rosenquist R, Cuppen E, Buettner R, Caldas C, Dreau H, Elemento O, et al. Clinical utility of whole-genome sequencing in precision oncology. Semin Cancer Biol. 2022;84:32\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.018 . PubMed PMID: 34175442.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3803_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrclinonc.2010.222","volume":"8","author":"T Tursz","year":"2011","unstructured":"Tursz T, Andre F, Lazar V, Lacroix L, Soria JC. Implications of personalized medicine\u2013perspective from a cancer center. Nat Rev Clin Oncol. 2011;8(3):177\u201383. https:\/\/doi.org\/10.1038\/nrclinonc.2010.222 . PubMed PMID: 21364691.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"3803_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3322\/caac.21844","volume":"74","author":"V Subbiah","year":"2024","unstructured":"Subbiah V, Gouda MA, Ryll B, Burris HA, Kurzrock R. The evolving landscape of tissue-agnostic therapies in precision oncology. CA Cancer J Clin. 2024;74(5):433\u201352. https:\/\/doi.org\/10.3322\/caac.21844 . PubMed PMID: 38814103.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3803_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10555","volume":"36","author":"FV Filipp","year":"2017","unstructured":"Filipp FV. Precision medicine driven by cancer systems biology. Cancer Metastasis Rev. 2017;36(1):91\u2013108. https:\/\/doi.org\/10.1007\/s10555-. 017-9662-4 PubMed PMID: 28265786; PubMed Central PMCID: PMC5385204.","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"3803_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMra2506017","volume":"394","author":"DE Citrin","year":"2026","unstructured":"Citrin DE, Timmerman RD. Effects of Radiotherapy in Normal Tissue. N Engl J Med. 2026;394(10):996\u20131009. doi:10.1056\/NEJMra2506017 PubMed PMID: 41780002.","journal-title":"N Engl J Med"},{"issue":"3","key":"3803_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.seminoncol.2019","volume":"46","author":"D Alterio","year":"2019","unstructured":"Alterio D, Marvaso G, Ferrari A, Volpe S, Orecchia R, Jereczek-Fossa BA. Modern radiotherapy for head and neck cancer. Semin Oncol. 2019;46(3):233\u201345. https:\/\/doi.org\/10.1053\/j.seminoncol.2019. 07.002 PubMed PMID: 31378376.","journal-title":"Semin Oncol"},{"issue":"10295","key":"3803_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0140-6736(","volume":"398","author":"RA Chandra","year":"2021","unstructured":"Chandra RA, Keane FK, Voncken FEM, Thomas CR. Contemporary radiotherapy: present and future. Lancet. 2021;398(10295):171\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(. 21)00233-6 PubMed PMID: 34166607.","journal-title":"Lancet"},{"issue":"4","key":"3803_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance. Cancer Cell. 2020;37(4):471\u201384. https:\/\/doi.org\/10.1016\/j.ccell. 2020.03.007 PubMed PMID: 32289271; PubMed Central PMCID: PMC7181408.","journal-title":"Cancer Cell"},{"issue":"2","key":"3803_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","volume":"98","author":"Y Ram\u00f3n","year":"2020","unstructured":"Ram\u00f3n Y, Cajal S, Ses\u00e9 M, Capdevila C, Aasen T, De Mattos-Arruda L, Diaz-Cano SJ, et al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med (Berl). 2020;98(2):161\u201377. https:\/\/doi.org\/10.1007\/s00109-020-01874-2 . PubMed PMID: 31970428; PubMed Central PMCID: PMC7007907.","journal-title":"J Mol Med (Berl)"},{"key":"3803_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.csbj.2024.12.020","volume":"27","author":"X Zhang","year":"2025","unstructured":"Zhang X, Xie J, Yang Z, Yu CKW, Hu Y, Qin J. Tumour heterogeneity and personalized treatment screening based on single-cell transcriptomics. Comput Struct Biotechnol J. 2025;27:307\u201320. https:\/\/doi.org\/10.1016\/j.csbj.2024.12.020 . PubMed PMID: 39877290; PubMed Central PMCID: PMC11773088.","journal-title":"Comput Struct Biotechnol J"},{"key":"3803_CR12","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1200\/EDBK_175524","volume":"37","author":"WS El-Deiry","year":"2017","unstructured":"El-Deiry WS, Taylor B, Neal JW. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come? Am Soc Clin Oncol Educ Book. 2017;37:e8\u201315. doi:10.1200\/EDBK_175524 PubMed PMID: 28746017.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"3803_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5(1):60. https:\/\/doi.org\/10.1038\/s41392-020-. 0150-x PubMed PMID: 32355263; PubMed Central PMCID: PMC7192953.","journal-title":"Signal Transduct Target Ther"},{"key":"3803_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-662","volume":"198","author":"K Borgmann","year":"2016","unstructured":"Borgmann K, K\u00f6cher S, Kriegs M, Mansour WY, Parplys AC, Rieckmann T, et al. DNA Repair Recent Results Cancer Res. 2016;198:1\u201324. https:\/\/doi.org\/10.1007\/978-3-662-. 49651-0_1 PubMed PMID: 27318679.","journal-title":"DNA Repair Recent Results Cancer Res"},{"issue":"19","key":"3803_CR15","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1016\/j.molcel","volume":"84","author":"B Xhemal\u00e7e","year":"2024","unstructured":"Xhemal\u00e7e B, Miller KM, Gromak N. Epitranscriptome in action: RNA modifications in the DNA damage response. Mol Cell. 2024;84(19):3610\u201326. https:\/\/doi.org\/10.1016\/j.molcel. 2024.09.003 PubMed PMID: 39366350; PubMed Central PMCID: PMC12044609.","journal-title":"Mol Cell"},{"issue":"1","key":"3803_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther. 2021;6(1):254. https:\/\/doi.org\/10.1038\/s41392-021-00648-7 . PubMed PMID: 34238917; PubMed Central PMCID: PMC8266832.","journal-title":"Signal Transduct Target Ther"},{"key":"3803_CR17","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera. .2020.107753 PubMed PMID: 33259885; PubMed Central PMCID: PMC8084948.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3803_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157. https:\/\/doi.org\/10.1186\/s12943-019-1089-9 . PubMed PMID: 31711497; PubMed Central PMCID: PMC6844052.","journal-title":"Mol Cancer"},{"issue":"6","key":"3803_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","volume":"6","author":"K Aliazis","year":"2025","unstructured":"Aliazis K, Christofides A, Shah R, Yeo YY, Jiang S, Charest A, et al. The tumor microenvironment\u2019s role in the response to immune checkpoint blockade. Nat Cancer. 2025;6(6):924\u201337. https:\/\/doi.org\/10.1038\/s43018-025-00986-3 . PubMed PMID: 40514448; PubMed Central PMCID: PMC12317369.","journal-title":"Nat Cancer"},{"issue":"7","key":"3803_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cmet","volume":"35","author":"W Zou","year":"2023","unstructured":"Zou W, Green DR. Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy. Cell Metab. 2023;35(7):1101\u201313. https:\/\/doi.org\/10.1016\/j.cmet. 2023.06.003 PubMed PMID: 37390822; PubMed Central PMCID: PMC10527949.","journal-title":"Cell Metab"},{"issue":"728","key":"3803_CR21","doi-asserted-by":"publisher","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets. Sci Transl Med. 2024;16(728):eadg3840. https:\/\/doi.org\/10.1126\/scitranslmed.adg. 3840 PubMed PMID: 38170791.","journal-title":"Sci Transl Med"},{"key":"3803_CR22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3389\/fonc.2019.01376","volume":"9","author":"SS Deville","year":"2019","unstructured":"Deville SS, Cordes N. The Extracellular, Cellular, and Nuclear Stiffness, a Trinity in the Cancer Resistome-A Review. Front Oncol. 2019;9:1376\u20131376. https:\/\/doi.org\/10.3389\/fonc.2019.01376.","journal-title":"Front Oncol"},{"issue":"6","key":"3803_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.trecan.2016.05","volume":"2","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Nam JM, Giaccia AJ. Hypoxia: Signaling the Metastatic Cascade. Trends Cancer. 2016;2(6):295\u2013304. https:\/\/doi.org\/10.1016\/j.trecan.2016.05. .006 PubMed PMID: 28741527; PubMed Central PMCID: PMC5808868.","journal-title":"Trends Cancer"},{"key":"3803_CR24","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1200\/EDBK_175561","volume":"37","author":"JD Weyandt","year":"2017","unstructured":"Weyandt JD, Thompson CB, Giaccia AJ, Rathmell WK. Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets. Am Soc Clin Oncol Educ Book. 2017;37:825\u201332. doi:10.1200\/EDBK_175561 PubMed PMID: 28561705; PubMed Central PMCID: PMC5954416.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"27","key":"3803_CR25","doi-asserted-by":"publisher","first-page":"13200","DOI":"10.1073\/pnas.1902035116","volume":"116","author":"F Alisafaei","year":"2019","unstructured":"Alisafaei F, Jokhun DS, Shivashankar GV, Shenoy VB. Regulation of nuclear architecture, mechanics, and nucleocytoplasmic shuttling of epigenetic factors by cell geometric constraints. Proc Natl Acad Sci U S A. 2019;116(27):13200\u20139. https:\/\/doi.org\/10.1073\/pnas.1902035116 . PubMed PMID: 31209017; PubMed Central PMCID: PMC6613080.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3803_CR26","doi-asserted-by":"publisher","first-page":"8541303","DOI":"10.1155\/2019\/8541303","volume":"2019","author":"L Wang","year":"2019","unstructured":"Wang L, Chen W. Modelling Cell Origami via a Tensegrity Model of the Cytoskeleton in Adherent Cells. Appl Bionics Biomech. 2019;2019:8541303. doi:10.1155\/2019\/8541303 PubMed PMID: 31485268; PubMed Central PMCID: PMC6710780.","journal-title":"Appl Bionics Biomech"},{"issue":"36","key":"3803_CR27","doi-asserted-by":"publisher","first-page":"e2203452119","DOI":"10.1073\/pnas.2203452119","volume":"119","author":"B Lebeau","year":"2022","unstructured":"Lebeau B, Jangal M, Zhao T, Wong CK, Wong N, Ca\u00f1edo EC, et al. 3D chromatin remodeling potentiates transcriptional programs driving cell invasion. Proc Natl Acad Sci U S A. 2022;119(36):e2203452119. https:\/\/doi.org\/10.1073\/pnas.2203452119 . PubMed PMID: 36037342; PubMed Central PMCID: PMC9457068.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3803_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41580-024-00719","volume":"25","author":"Y Mao","year":"2024","unstructured":"Mao Y, Wickstr\u00f6m SA. Mechanical state transitions in the regulation of tissue form and function. Nat Rev Mol Cell Biol. 2024;25(8):654\u201370. https:\/\/doi.org\/10.1038\/s41580-024-00719. -x PubMed PMID: 38600372.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7 Suppl","key":"3803_CR29","first-page":"1757","volume":"59","author":"MJ Bissell","year":"1999","unstructured":"Bissell MJ, Weaver VM, Leli\u00e8vre SA, Wang F, Petersen OW, Schmeichel KL. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 1999;59(7 Suppl):1757\u2013s1763. discussion 1763s-1764s. PubMed PMID: 10197593.","journal-title":"Cancer Res"},{"key":"3803_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcdb","volume":"67","author":"PM Gilbert","year":"2017","unstructured":"Gilbert PM, Weaver VM. Cellular adaptation to biomechanical stress across length scales in tissue homeostasis and disease. Semin Cell Dev Biol. 2017;67:141\u201352. https:\/\/doi.org\/10.1016\/j.semcdb. .2016.09.004 PubMed PMID: 27641825; PubMed Central PMCID: PMC5352546.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"3803_CR31","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-025-56299-7","volume":"16","author":"O Maiques","year":"2025","unstructured":"Maiques O, Sallan MC, Laddach R, Pandya P, Varela A, Crosas-Molist E, et al. Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis. Nat Commun. 2025;16(1):1394. https:\/\/doi.org\/10.1038\/s41467-025-56299-7 . PubMed PMID: 39952917; PubMed Central PMCID: PMC11829002.","journal-title":"Nat Commun"},{"issue":"9","key":"3803_CR32","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41556-020-0552-6","volume":"22","author":"O Ilina","year":"2020","unstructured":"Ilina O, Gritsenko PG, Syga S, Lippoldt J, La Porta CAM, Chepizhko O, et al. Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion. Nat Cell Biol. 2020;22(9):1103\u201315. https:\/\/doi.org\/10.1038\/s41556-020-0552-6 . PubMed PMID: 32839548; PubMed Central PMCID: PMC7502685.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"3803_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.radonc.2011.06.007","volume":"99","author":"I Eke","year":"2011","unstructured":"Eke I, Cordes N. Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation. Radiother Oncol. 2011;99(3):271\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2011.06.007 . PubMed PMID: 21704412.","journal-title":"Radiother Oncol"},{"issue":"10","key":"3803_CR34","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1158\/0008-5472.CAN-09-3848","volume":"70","author":"K Storch","year":"2010","unstructured":"Storch K, Eke I, Borgmann K, Krause M, Richter C, Becker K, et al. Three-dimensional cell growth confers radioresistance by chromatin density modification. Cancer Res. 2010;70(10):3925\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3848.","journal-title":"Cancer Res"},{"issue":"1","key":"3803_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s43018-025","volume":"7","author":"L Ma","year":"2026","unstructured":"Ma L, Xiong B, Liu M, Tan K. Cellular neighborhoods in cancer. Nat Cancer. 2026;7(1):16\u201328. https:\/\/doi.org\/10.1038\/s43018-025-. 01107-w PubMed PMID: 41545713.","journal-title":"Nat Cancer"},{"issue":"1","key":"3803_CR36","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1186\/s12967-025-07390-6","volume":"23","author":"L Du","year":"2025","unstructured":"Du L, Yang H. Spatial omics in 3D culture model systems: decoding cellular positioning mechanisms and microenvironmental dynamics. J Transl Med. 2025;23(1):1356. https:\/\/doi.org\/10.1186\/s12967-025-07390-6 . PubMed PMID: 41299674; PubMed Central PMCID: PMC12659358.","journal-title":"J Transl Med"},{"issue":"10","key":"3803_CR37","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ccell.2024.09","volume":"42","author":"D Gong","year":"2024","unstructured":"Gong D, Arbesfeld-Qiu JM, Perrault E, Bae JW, Hwang WL. Spatial oncology: Translating contextual biology to the clinic. Cancer Cell. 2024;42(10):1653\u201375. https:\/\/doi.org\/10.1016\/j.ccell.2024.09. .001 PubMed PMID: 39366372; PubMed Central PMCID: PMC12051486.","journal-title":"Cancer Cell"},{"key":"3803_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","volume":"31","author":"I Eke","year":"2015","unstructured":"Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015;31:65\u201375. https:\/\/doi.org\/10.1016\/j.semcancer.2014.07.009 . PubMed PMID: 25117005.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"3803_CR39","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673\u201387.","journal-title":"Cell"},{"issue":"1","key":"3803_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41556-018-0234-9","volume":"21","author":"Z Sun","year":"2019","unstructured":"Sun Z, Costell M, F\u00e4ssler R. Integrin activation by talin, kindlin and mechanical forces. Nat Cell Biol. 2019;21(1):25\u201331. https:\/\/doi.org\/10.1038\/s41556-018-0234-9 . PubMed PMID: 30602766.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3803_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrm1789","volume":"7","author":"KR Legate","year":"2006","unstructured":"Legate KR, Monta\u00f1ez E, Kudlacek O, F\u00e4ssler R, ILK. PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol. 2006;7(1):20\u201331. https:\/\/doi.org\/10.1038\/nrm1789.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"3803_CR42","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891\u2013906. https:\/\/doi.org\/10.1016\/j.cell.2009.10.027 . PubMed PMID: 19931152; PubMed Central PMCID: PMC2788004.","journal-title":"Cell"},{"issue":"3","key":"3803_CR43","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1073\/pnas.94.3.849","volume":"94","author":"AJ Maniotis","year":"1997","unstructured":"Maniotis AJ, Chen CS, Ingber DE. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci U S A. 1997;94(3):849\u201354. https:\/\/doi.org\/10.1073\/pnas.94.3.849 . PubMed PMID: 9023345; PubMed Central PMCID: PMC19602.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3803_CR44","doi-asserted-by":"publisher","first-page":"113322","DOI":"10.1016\/j.celrep.2023.113322","volume":"42","author":"Z Sun","year":"2023","unstructured":"Sun Z, Cernilogar FM, Horvatic H, Yeroslaviz A, Abdullah Z, Schotta G, et al. \u03b21 integrin signaling governs necroptosis via the chromatin-remodeling factor CHD4. Cell Rep. 2023;42(11):113322. https:\/\/doi.org\/10.1016\/j.celrep.2023.113322 . PubMed PMID: 37883227.","journal-title":"Cell Rep"},{"issue":"7350","key":"3803_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474(7350):179\u201383. https:\/\/doi.org\/10.1038\/nature10137 . PubMed PMID: 21654799.","journal-title":"Nature"},{"key":"3803_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-cellbio-092910-154017","volume":"27","author":"J Ivaska","year":"2011","unstructured":"Ivaska J, Heino J. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu Rev Cell Dev Biol. 2011;27:291\u2013320. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154017.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"3803_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S1359-6101(00)00022-8","volume":"12","author":"A Schlegel","year":"2001","unstructured":"Schlegel A, Lisanti MP. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine Growth Factor Rev. 2001;12(1):41\u201351.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"3803_CR48","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571\u201384. https:\/\/doi.org\/10.1038\/s41580-020-0259-3 . PubMed PMID: 32636524; PubMed Central PMCID: PMC7339799.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3803_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1083\/jcb.201610056","volume":"216","author":"M Simian","year":"2017","unstructured":"Simian M, Bissell MJ, Organoids. A historical perspective of thinking in three dimensions. J Cell Biol. 2017;216(1):31\u201340. https:\/\/doi.org\/10.1083\/jcb.201610056 . PubMed PMID: 28031422; PubMed Central PMCID: PMC5223613.","journal-title":"J Cell Biol"},{"issue":"7","key":"3803_CR50","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H. Modeling Development and Disease with Organoids. Cell. 2016;165(7):1586\u201397. https:\/\/doi.org\/10.1016\/j.cell.2016. 05.082 PubMed PMID: 27315476.","journal-title":"Cell"},{"issue":"7","key":"3803_CR51","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/bios14070336","volume":"14","author":"C Li","year":"2024","unstructured":"Li C, He W, Song Y, Zhang X, Sun J, Zhou Z. Advances of 3D Cell Co-Culture Technology Based on Microfluidic Chips. Biosens (Basel). 2024;14(7):336. https:\/\/doi.org\/10.3390\/bios14070336 . PubMed PMID: 39056612; PubMed Central PMCID: PMC11274478.","journal-title":"Biosens (Basel)"},{"issue":"12","key":"3803_CR52","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.tibtech.2024","volume":"42","author":"IL Co","year":"2024","unstructured":"Co IL, Fomina A, Nurse M, McGuigan AP. Applications and evolution of 3D cancer-immune cell models. Trends Biotechnol. 2024;42(12):1615\u201327. https:\/\/doi.org\/10.1016\/j.tibtech.2024. 06.008 PubMed PMID: 39025680.","journal-title":"Trends Biotechnol"},{"issue":"7","key":"3803_CR53","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41580-023-00583-1","volume":"24","author":"A Saraswathibhatla","year":"2023","unstructured":"Saraswathibhatla A, Indana D, Chaudhuri O. Cell-extracellular matrix mechanotransduction in 3D. Nat Rev Mol Cell Biol. 2023;24(7):495\u2013516. https:\/\/doi.org\/10.1038\/s41580-023-00583-1 . PubMed PMID: 36849594; PubMed Central PMCID: PMC10656994.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"3803_CR54","doi-asserted-by":"publisher","first-page":"10620","DOI":"10.3390\/ijms241310620","volume":"24","author":"F Antonelli","year":"2023","unstructured":"Antonelli F. 3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research. Int J Mol Sci. 2023;24(13):10620. :10.3390\/ijms241310620 PubMed PMID: 37445795; PubMed Central PMCID: PMC10341460.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3803_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4(4):359\u201365. https:\/\/doi.org\/10.1038\/nmeth1015 . PubMed PMID: 17396127; PubMed Central PMCID: PMC2933182.","journal-title":"Nat Methods"},{"issue":"Pt 12","key":"3803_CR56","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1242\/jcs.00503","volume":"116","author":"KL Schmeichel","year":"2003","unstructured":"Schmeichel KL, Bissell MJ. Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci. 2003;116(Pt 12):2377\u201388. https:\/\/doi.org\/10.1242\/jcs.00503 . PubMed PMID: 12766184; PubMed Central PMCID: PMC2933213.","journal-title":"J Cell Sci"},{"issue":"2","key":"3803_CR57","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/s0360-3016","volume":"49","author":"RP Hill","year":"2001","unstructured":"Hill RP, Rodemann HP, Hendry JH, Roberts SA, Anscher MS. Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys. 2001;49(2):353\u201365. https:\/\/doi.org\/10.1016\/s0360-3016. (00)01484-x PubMed PMID: 11173128.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"3803_CR58","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/cells9122649","volume":"9","author":"PW Nagle","year":"2020","unstructured":"Nagle PW, Coppes RP. Current and Future Perspectives of the Use of Organoids in Radiobiology. Cells. 2020;9(12):2649. doi:10.3390\/cells9122649 PubMed PMID: 33317153; PubMed Central PMCID: PMC7764598.","journal-title":"Cells"},{"issue":"3","key":"3803_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1053\/srao","volume":"11","author":"EL Travis","year":"2001","unstructured":"Travis EL. Organizational response of normal tissues to irradiation. Semin Radiat Oncol. 2001;11(3):184\u201396. https:\/\/doi.org\/10.1053\/srao. 2001.25243 PubMed PMID: 11447575.","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"3803_CR60","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrc3536","volume":"13","author":"MH Barcellos-Hoff","year":"2013","unstructured":"Barcellos-Hoff MH, Lyden D, Wang TC. The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer. 2013;13(7):511\u20138. https:\/\/doi.org\/10.1038\/nrc3536 . PubMed PMID: 23760023.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3803_CR61","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s1357-4310","volume":"6","author":"CC Park","year":"2000","unstructured":"Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today. 2000;6(8):324\u20139. https:\/\/doi.org\/10.1016\/s1357-4310. (00)01756-1 PubMed PMID: 10904250.","journal-title":"Mol Med Today"},{"issue":"6","key":"3803_CR62","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.trecan.2022","volume":"8","author":"J Almagro","year":"2022","unstructured":"Almagro J, Messal HA, Elosegui-Artola A, van Rheenen J, Behrens A. Tissue architecture in tumor initiation and progression. Trends Cancer. 2022;8(6):494\u2013505. https:\/\/doi.org\/10.1016\/j.trecan.2022. 02.007 PubMed PMID: 35300951.","journal-title":"Trends Cancer"},{"issue":"9","key":"3803_CR63","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1158\/0008-5472","volume":"79","author":"FM White","year":"2019","unstructured":"White FM, Gatenby RA, Fischbach C. The Physics of Cancer. Cancer Res. 2019;79(9):2107\u201310. https:\/\/doi.org\/10.1158\/0008-5472. .CAN-18-3937 PubMed PMID: 31018939; PubMed Central PMCID: PMC6497564.","journal-title":"Cancer Res"},{"issue":"9","key":"3803_CR64","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.chembiol","volume":"30","author":"GP Lobel","year":"2023","unstructured":"Lobel GP, Jiang Y, Simon MC. Tumor microenvironmental nutrients, cellular responses, and cancer. Cell Chem Biol. 2023;30(9):1015\u201332. https:\/\/doi.org\/10.1016\/j.chembiol. 2023.08.011 PubMed PMID: 37703882; PubMed Central PMCID: PMC10528750.","journal-title":"Cell Chem Biol"},{"key":"3803_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coisb.2017.04.005","volume":"2","author":"CR Pfeifer","year":"2017","unstructured":"Pfeifer CR, Alvey CM, Irianto J, Discher DE. Genome variation across cancers scales with tissue stiffness - an invasion-mutation mechanism and implications for immune cell infiltration. Curr Opin Syst Biol. 2017;2:103\u201314. https:\/\/doi.org\/10.1016\/j.coisb.2017.04.005 . PubMed PMID: 29082336; PubMed Central PMCID: PMC5654613.","journal-title":"Curr Opin Syst Biol"},{"issue":"1","key":"3803_CR66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1158\/0008-5472.CAN-12-2021","volume":"73","author":"I Eke","year":"2013","unstructured":"Eke I, Schneider L, F\u00f6rster C, Zips D, Kunz-Schughart LA, Cordes N. EGFR\/JIP-4\/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cells. Cancer Res. 2013;73(1):297\u2013306. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2021.","journal-title":"Cancer Res"},{"issue":"1","key":"3803_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12943-025-02374-y","volume":"24","author":"JS Kim","year":"2025","unstructured":"Kim JS, Park CH, Kim E, Lee HS, Lee J, Kim J, et al. Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer. Mol Cancer. 2025;24(1):162. https:\/\/doi.org\/10.1186\/s12943-025-02374-y . PubMed PMID: 40462147; PubMed Central PMCID: PMC12131615.","journal-title":"Mol Cancer"},{"issue":"5","key":"3803_CR68","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, et al. Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer Discov. 2017;7(5):462\u201377. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1154 . PubMed PMID: 28331002; PubMed Central PMCID: PMC5413423.","journal-title":"Cancer Discov"},{"issue":"3","key":"3803_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4(3):309\u201324. https:\/\/doi.org\/10.1038\/nprot.2008.226 . PubMed PMID: 19214182.","journal-title":"Nat Protoc"},{"issue":"1","key":"3803_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald LB, Bellet D, Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia. 2015;17(1):1\u201315. https:\/\/doi.org\/10.1016\/j.neo. .2014.12.004 PubMed PMID: 25622895; PubMed Central PMCID: PMC4309685.","journal-title":"Neoplasia"},{"key":"3803_CR71","doi-asserted-by":"publisher","unstructured":"Pe\u00f1as KED, Haeusler R, Feng S, Magidson V, Dmitrieva M, Wink D et al. Profiling DNA damage in 3D Histology Samples. Med Opt Imaging Virtual Microsc Image Anal (2022). 2022;84\u201393. https:\/\/doi.org\/10.1007\/978-3-031-16961-8_9 PubMed PMID: 39899002; PubMed Central PMCID: PMC7617225.","DOI":"10.1007\/978-3-031-16961-8_9"},{"key":"3803_CR72","doi-asserted-by":"publisher","first-page":"123184","DOI":"10.1016\/j.lfs.2024.123184","volume":"358","author":"T Patel","year":"2024","unstructured":"Patel T, Jain N. Multicellular tumor spheroids: A convenient in vitro model for translational cancer research. Life Sci. 2024;358:123184. https:\/\/doi.org\/10.1016\/j.lfs.2024.123184 . PubMed PMID: 39490437.","journal-title":"Life Sci"},{"issue":"17","key":"3803_CR73","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1158\/1078-0432.CCR-18-3590","volume":"25","author":"CA Pasch","year":"2019","unstructured":"Pasch CA, Favreau PF, Yueh AE, Babiarz CP, Gillette AA, Sharick JT, et al. Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation. Clin Cancer Res. 2019;25(17):5376\u201387. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3590 . PubMed PMID: 31175091; PubMed Central PMCID: PMC6726566.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3803_CR74","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41596-023-00839-2","volume":"18","author":"C Lago","year":"2023","unstructured":"Lago C, Gianesello M, Santomaso L, Leva G, Ballabio C, Anderle M, et al. Medulloblastoma and high-grade glioma organoids for drug screening, lineage tracing, co-culture and in vivo assay. Nat Protoc. 2023;18(7):2143\u201380. https:\/\/doi.org\/10.1038\/s41596-023-00839-2 . PubMed PMID: 37248391.","journal-title":"Nat Protoc"},{"issue":"1","key":"3803_CR75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-00994","volume":"31","author":"WH Abuwatfa","year":"2024","unstructured":"Abuwatfa WH, Pitt WG, Husseini GA. Scaffold-based 3D cell culture models in cancer research. J Biomed Sci. 2024;31(1):7. https:\/\/doi.org\/10.1186\/s12929-024-00994-. y PubMed PMID: 38221607; PubMed Central PMCID: PMC10789053.","journal-title":"J Biomed Sci"},{"issue":"9","key":"3803_CR76","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nrc1695","volume":"5","author":"J Debnath","year":"2005","unstructured":"Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005;5(9):675\u201388. https:\/\/doi.org\/10.1038\/nrc1695 . PubMed PMID: 16148884.","journal-title":"Nat Rev Cancer"},{"issue":"1\u20132","key":"3803_CR77","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell. 2018;172(1\u20132):373\u2013e38610. https:\/\/doi.org\/10.1016\/j.cell.2017.11.010.","journal-title":"Cell"},{"key":"3803_CR78","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31:51\u201372. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-100008 . PubMed PMID: 23157435.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"3803_CR79","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, et al. Organoid Modeling of the Tumor Immune Microenvironment. Cell. 2018;175(7):1972\u2013e198816. https:\/\/doi.org\/10.1016\/j.cell.2018.11.021 . PubMed PMID: 30550791; PubMed Central PMCID: PMC6656687.","journal-title":"Cell"},{"issue":"6","key":"3803_CR80","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, et al. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids. Cell. 2018;174(6):1586\u2013e159812. https:\/\/doi.org\/10.1016\/j.cell.2018.07.009 . PubMed PMID: 30100188; PubMed Central PMCID: PMC6558289.","journal-title":"Cell"},{"key":"3803_CR81","doi-asserted-by":"publisher","unstructured":"Cordes N, Meineke V. Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlenther Onkol. 2003\/05\/13 ed. 2003;179(5):337\u201344. https:\/\/doi.org\/10.1007\/s00066-003-1074-4","DOI":"10.1007\/s00066-003-1074-4"},{"issue":"2","key":"3803_CR82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/bjc.1984.156","volume":"50","author":"CM West","year":"1984","unstructured":"West CM, Sandhu RR, Stratford IJ. The radiation response of V79 and human tumour multicellular spheroids\u2013cell survival and growth delay studies. Br J Cancer. 1984;50(2):143\u201351. https:\/\/doi.org\/10.1038\/bjc.1984.156 . PubMed PMID: 6087864; PubMed Central PMCID: PMC1976873.","journal-title":"Br J Cancer"},{"issue":"11","key":"3803_CR83","doi-asserted-by":"publisher","first-page":"16708","DOI":"10.1021\/acsami.5c02296","volume":"17","author":"AD Kataki","year":"2025","unstructured":"Kataki AD, Gupta PG, Cheema U, Nisbet A, Wang Y, Kocher HM, et al. Mapping Tumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic Cancer. ACS Appl Mater Interfaces. 2025;17(11):16708\u201324. https:\/\/doi.org\/10.1021\/acsami.5c02296 . PubMed PMID: 40052705; PubMed Central PMCID: PMC11931495.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"15","key":"3803_CR84","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.3390\/cancers14153810","volume":"14","author":"M Millet","year":"2022","unstructured":"Millet M, Bollmann E, Ringuette Goulet C, Bernard G, Chabaud S, Huot M\u00c9, et al. Cancer-Associated Fibroblasts in a 3D Engineered Tissue Model Induce Tumor-like Matrix Stiffening and EMT Transition. Cancers (Basel). 2022;14(15):3810. https:\/\/doi.org\/10.3390\/cancers14153810 . PubMed PMID: 35954473; PubMed Central PMCID: PMC9367573.","journal-title":"Cancers (Basel)"},{"issue":"23","key":"3803_CR85","doi-asserted-by":"publisher","first-page":"e1805510","DOI":"10.1002\/smll.201805510","volume":"15","author":"MA Heinrich","year":"2019","unstructured":"Heinrich MA, Liu W, Jimenez A, Yang J, Akpek A, Liu X, et al. 3D Bioprinting: from Benches to Translational Applications. Small. 2019;15(23):e1805510. https:\/\/doi.org\/10.1002\/smll.201805510 . PubMed PMID: 31033203; PubMed Central PMCID: PMC6752725.","journal-title":"Small"},{"issue":"1","key":"3803_CR86","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1038\/s41598-018-21200-8","volume":"8","author":"AR Mazzocchi","year":"2018","unstructured":"Mazzocchi AR, Rajan SAP, Votanopoulos KI, Hall AR, Skardal A. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening. Sci Rep. 2018;8(1):2886. https:\/\/doi.org\/10.1038\/s41598-018-21200-8 . PubMed PMID: 29440675; PubMed Central PMCID: PMC5811529.","journal-title":"Sci Rep"},{"issue":"21","key":"3803_CR87","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1039\/d5lc00003c","volume":"25","author":"MT Birtek","year":"2025","unstructured":"Birtek MT, Atceken N, Tasoglu S. Programmable 3DP microfluidic bio-reaction system: automated LAMP-on-a-chip. Lab Chip. 2025;25(21):5506\u201323. https:\/\/doi.org\/10.1039\/d5lc00003c . PubMed PMID: 40779684.","journal-title":"Lab Chip"},{"issue":"8","key":"3803_CR88","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32(8):760\u201372. https:\/\/doi.org\/10.1038\/nbt.2989 . PubMed PMID: 25093883.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"3803_CR89","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41551-019-0363-x","volume":"3","author":"HG Yi","year":"2019","unstructured":"Yi HG, Jeong YH, Kim Y, Choi YJ, Moon HE, Park SH, et al. A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nat Biomed Eng. 2019;3(7):509\u201319. https:\/\/doi.org\/10.1038\/s41551-019-0363-x . PubMed PMID: 31148598.","journal-title":"Nat Biomed Eng"},{"issue":"18","key":"3803_CR90","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1073\/pnas.0907676107","volume":"107","author":"V Vaira","year":"2010","unstructured":"Vaira V, Fedele G, Pyne S, Fasoli E, Zadra G, Bailey D, et al. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci U S A. 2010;107(18):8352\u20136. https:\/\/doi.org\/10.1073\/pnas.0907676107 . PubMed PMID: 20404174; PubMed Central PMCID: PMC2889536.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3803_CR91","doi-asserted-by":"publisher","first-page":"e70267","DOI":"10.1002\/biot.70267","volume":"21","author":"LJ Yao","year":"2026","unstructured":"Yao LJ, Xie PL, Huang TX, Xiao JS, Zhu ZT, Liu S, et al. 3D Bioprinting for Tumor Microenvironment Reconstruction: Advances, Challenges, and Future Perspectives. Biotechnol J. 2026;21(6):e70267. https:\/\/doi.org\/10.1002\/biot.70267 . PubMed PMID: 42307057.","journal-title":"Biotechnol J"},{"issue":"1","key":"3803_CR92","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-017-0570-9","volume":"36","author":"S Riffle","year":"2017","unstructured":"Riffle S, Hegde RS. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids. J Exp Clin Cancer Res. 2017;36(1):102. https:\/\/doi.org\/10.1186\/s13046-017-0570-9 . PubMed PMID: 28774341; PubMed Central PMCID: PMC5543535.","journal-title":"J Exp Clin Cancer Res"},{"key":"3803_CR93","doi-asserted-by":"publisher","first-page":"111288","DOI":"10.1016\/j.radonc.2025.111288","volume":"214","author":"D Est\u00eav\u00e3o","year":"2026","unstructured":"Est\u00eav\u00e3o D, da Cruz-Ribeiro M, Canha-Borges A, Macedo-Silva C, Castro F, Lencart J, et al. Novel rectal cancer spheroid models reveal metabolic and transcriptional adaptations driving radiotherapy response. Radiother Oncol. 2026;214:111288. https:\/\/doi.org\/10.1016\/j.radonc.2025.111288 . PubMed PMID: 41248697.","journal-title":"Radiother Oncol"},{"issue":"11","key":"3803_CR94","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/onc.2015.212","volume":"35","author":"E Dickreuter","year":"2016","unstructured":"Dickreuter E, Eke I, Krause M, Borgmann K, van Vugt MA, Cordes N. Targeting of \u03b21 integrins impairs DNA repair for radiosensitization of head and neck cancer cells. Oncogene. 2016;35(11):1353\u201362. https:\/\/doi.org\/10.1038\/onc.2015.212.","journal-title":"Oncogene"},{"issue":"7","key":"3803_CR95","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cancers12071717","volume":"12","author":"SS Deville","year":"2020","unstructured":"Deville SS, Vehlow A, F\u00f6rster S, Dickreuter E, Borgmann K, Cordes N. The Intermediate Filament Synemin Regulates Non-Homologous End Joining in an ATM-Dependent Manner. Cancers (Basel). 2020;12(7):1717. https:\/\/doi.org\/10.3390\/cancers12071717 . PubMed PMID: 32605308; PubMed Central PMCID: PMC7407367.","journal-title":"Cancers (Basel)"},{"key":"3803_CR96","doi-asserted-by":"publisher","first-page":"19103","DOI":"10.1038\/srep19103","volume":"6","author":"M Zanoni","year":"2016","unstructured":"Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016;6:19103. https:\/\/doi.org\/10.1038\/srep19103 . PubMed PMID: 26752500; PubMed Central PMCID: PMC4707510.","journal-title":"Sci Rep"},{"issue":"18","key":"3803_CR97","doi-asserted-by":"publisher","first-page":"20778","DOI":"10.1021\/acsami.2c03706","volume":"14","author":"Q Akolawala","year":"2022","unstructured":"Akolawala Q, Rovituso M, Versteeg HH, Rondon AMR, Accardo A. Evaluation of Proton-Induced DNA Damage in 3D-Engineered Glioblastoma Microenvironments. ACS Appl Mater Interfaces. 2022;14(18):20778\u201389. https:\/\/doi.org\/10.1021\/acsami.2c03706 . PubMed PMID: 35442634; PubMed Central PMCID: PMC9100514.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"3803_CR98","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1021\/acsami.4","volume":"17","author":"Q Akolawala","year":"2025","unstructured":"Akolawala Q, Accardo A. Engineered Cell Microenvironments: A Benchmark Tool for Radiobiology. ACS Appl Mater Interfaces. 2025;17(4):5563\u201377. https:\/\/doi.org\/10.1021\/acsami.4. c20455 PubMed PMID: 39813590; PubMed Central PMCID: PMC11788991.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"3803_CR99","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/0014-4827(72)90265-0","volume":"93","author":"JS Damiano","year":"1999","unstructured":"Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood. 1999;93(5):1658\u201367. https:\/\/doi.org\/10.1016\/0014-4827(72)90265-0.","journal-title":"Blood"},{"issue":"9","key":"3803_CR100","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc2714","volume":"9","author":"MB Meads","year":"2009","unstructured":"Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer. 2009;9(9):665\u201374. https:\/\/doi.org\/10.1038\/nrc2714.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3803_CR101","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.14440\/jbm.2015.96","volume":"2","author":"I Eke","year":"2015","unstructured":"Eke I, Hehlgans S, Zong Y, Cordes N. Comprehensive analysis of signal transduction in three-dimensional ECM-based tumor cell cultures. J Biol methods. 2015;2(4):e31\u201331. https:\/\/doi.org\/10.14440\/jbm.2015.96.","journal-title":"J Biol methods"},{"issue":"9","key":"3803_CR102","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac H, Belleau P, Engle DD, Plenker D, Desch\u00eanes A, Somerville TDD, et al. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018;8(9):1112\u201329. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0349 . PubMed PMID: 29853643; PubMed Central PMCID: PMC6125219.","journal-title":"Cancer Discov"},{"issue":"11","key":"3803_CR103","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","volume":"5","author":"L Tong","year":"2024","unstructured":"Tong L, Cui W, Zhang B, Fonseca P, Zhao Q, Zhang P, et al. Patient-derived organoids in precision cancer medicine. Med. 2024;5(11):1351\u201377. 08.010 PubMed PMID: 39341206.","journal-title":"Med"},{"issue":"1","key":"3803_CR104","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12964-024-01884-4","volume":"22","author":"H Xu","year":"2024","unstructured":"Xu H, Wen J, Yang J, Zhou S, Li Y, Xu K, et al. Tumor-microenvironment-on-a-chip: the construction and application. Cell Commun Signal. 2024;22(1):515. https:\/\/doi.org\/10.1186\/s12964-024-01884-4 . PubMed PMID: 39438954; PubMed Central PMCID: PMC11515741.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"3803_CR105","doi-asserted-by":"publisher","first-page":"e006290","DOI":"10.1136\/jitc-2022-006290","volume":"11","author":"L Magr\u00e9","year":"2023","unstructured":"Magr\u00e9 L, Verstegen MMA, Buschow S, van der Laan LJW, Peppelenbosch M, Desai J. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies. J Immunother Cancer. 2023;11(5):e006290. https:\/\/doi.org\/10.1136\/jitc-2022-006290 . PubMed PMID: 37220953; PubMed Central PMCID: PMC10231025.","journal-title":"J Immunother Cancer"},{"issue":"10","key":"3803_CR106","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.ccell.2025.06.012","volume":"43","author":"KK Dijkstra","year":"2025","unstructured":"Dijkstra KK, Vendramin R, Karagianni D, Witsen M, G\u00e1lvez-Cancino F, Hill MS, et al. Subclonal immune evasion in non-small cell lung cancer. Cancer Cell. 2025;43(10):1833\u2013e184910. https:\/\/doi.org\/10.1016\/j.ccell.2025.06.012 . PubMed PMID: 40614739.","journal-title":"Cancer Cell"},{"issue":"2","key":"3803_CR107","doi-asserted-by":"publisher","first-page":"101307","DOI":"10.1016\/j.crmeth.2026.101307","volume":"6","author":"EA Hanna","year":"2026","unstructured":"Hanna EA, Crawford AJ, Du W, Johnston A, Schell D, Wan Z, et al. A 3D multi-compartment assembloid to study combined immune cell infiltration and cytotoxicity. Cell Rep Methods. 2026;6(2):101307. https:\/\/doi.org\/10.1016\/j.crmeth.2026.101307 . PubMed PMID: 41690308; PubMed Central PMCID: PMC12946747.","journal-title":"Cell Rep Methods"},{"issue":"2","key":"3803_CR108","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tcb.2019","volume":"30","author":"RM Marton","year":"2020","unstructured":"Marton RM, Pa\u0219ca SP. Organoid and Assembloid Technologies for Investigating Cellular Crosstalk in Human Brain Development and Disease. Trends Cell Biol. 2020;30(2):133\u201343. https:\/\/doi.org\/10.1016\/j.tcb.2019. 11.004 PubMed PMID: 31879153.","journal-title":"Trends Cell Biol"},{"issue":"7839","key":"3803_CR109","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-020","volume":"588","author":"E Kim","year":"2020","unstructured":"Kim E, Choi S, Kang B, Kong J, Kim Y, Yoon WH, et al. Creation of bladder assembloids mimicking tissue regeneration and cancer. Nature. 2020;588(7839):664\u20139. https:\/\/doi.org\/10.1038\/s41586-020-. 3034-x PubMed PMID: 33328632.","journal-title":"Nature"},{"issue":"1","key":"3803_CR110","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Hu Q, Pei Y, Luo H, Wang Z, Xu X, et al. A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments. Nat Commun. 2024;15(1):3382. https:\/\/doi.org\/10.1038\/s41467-024-47737-z . PubMed PMID: 38643164; PubMed Central PMCID: PMC11032376.","journal-title":"Nat Commun"},{"issue":"7825","key":"3803_CR111","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-020-2712-z","volume":"585","author":"B Palikuqi","year":"2020","unstructured":"Palikuqi B, Nguyen DHT, Li G, Schreiner R, Pellegata AF, Liu Y, et al. Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis. Nature. 2020;585(7825):426\u201332. https:\/\/doi.org\/10.1038\/s41586-020-2712-z . PubMed PMID: 32908310; PubMed Central PMCID: PMC7480005.","journal-title":"Nature"},{"issue":"10","key":"3803_CR112","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1039\/d2bm02060b","volume":"11","author":"R Sharma","year":"2023","unstructured":"Sharma R, Restan Perez M, da Silva VA, Thomsen J, Bhardwaj L, Andrade TAM, et al. 3D bioprinting complex models of cancer. Biomater Sci. 2023;11(10):3414\u201330. https:\/\/doi.org\/10.1039\/d2bm02060b . PubMed PMID: 37000528.","journal-title":"Biomater Sci"},{"issue":"4","key":"3803_CR113","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cell.2006","volume":"126","author":"AJ Engler","year":"2006","unstructured":"Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126(4):677\u201389. https:\/\/doi.org\/10.1016\/j.cell.2006. 06.044 PubMed PMID: 16923388.","journal-title":"Cell"},{"issue":"3","key":"3803_CR114","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nmat4489","volume":"15","author":"O Chaudhuri","year":"2016","unstructured":"Chaudhuri O, Gu L, Klumpers D, Darnell M, Bencherif SA, Weaver JC, et al. Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat Mater. 2016;15(3):326\u201334. https:\/\/doi.org\/10.1038\/nmat4489 . PubMed PMID: 26618884; PubMed Central PMCID: PMC4767627.","journal-title":"Nat Mater"},{"issue":"1","key":"3803_CR115","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","volume":"7","author":"XY Tang","year":"2022","unstructured":"Tang XY, Wu S, Wang D, Chu C, Hong Y, Tao M, et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022;7(1):168. https:\/\/doi.org\/10.1038\/s41392-022-01024-9 . PubMed PMID: 35610212; PubMed Central PMCID: PMC9127490.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3803_CR116","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MMA Verstegen","year":"2025","unstructured":"Verstegen MMA, Coppes RP, Beghin A, De Coppi P, Gerli MFM, de Graeff N, et al. Clinical applications of human organoids. Nat Med. 2025;31(2):409\u201321. https:\/\/doi.org\/10.1038\/s41591-024-03489-3 . PubMed PMID: 39901045.","journal-title":"Nat Med"},{"issue":"6","key":"3803_CR117","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/stmcls\/sxae023","volume":"42","author":"A Soto-Gamez","year":"2024","unstructured":"Soto-Gamez A, Gunawan JP, Barazzuol L, Pringle S, Coppes RP. Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation. Stem Cells. 2024;42(6):499\u2013508. https:\/\/doi.org\/10.1093\/stmcls\/sxae023 . PubMed PMID: 38525972; PubMed Central PMCID: PMC11177156.","journal-title":"Stem Cells"},{"issue":"8","key":"3803_CR118","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17(8):457\u201374. https:\/\/doi.org\/10.1038\/nrc.2017.51 . PubMed PMID: 28706266.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3803_CR119","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb433","volume":"9","author":"A Wodarz","year":"2007","unstructured":"Wodarz A, N\u00e4thke I. Cell polarity in development and cancer. Nat Cell Biol. 2007;9(9):1016\u201324. https:\/\/doi.org\/10.1038\/ncb433 . PubMed PMID: 17762893.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3803_CR120","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc3169","volume":"12","author":"F Martin-Belmonte","year":"2011","unstructured":"Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer. 2011;12(1):23\u201338. https:\/\/doi.org\/10.1038\/nrc3169 . PubMed PMID: 22169974.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3803_CR121","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/1097-0142(19861015)58:8<1668::aid-cncr2820580816>3","volume":"58","author":"RM Sutherland","year":"1986","unstructured":"Sutherland RM. Importance of critical metabolites and cellular interactions in the biology of microregions of tumors. Cancer. 1986;58(8):1668\u201380. https:\/\/doi.org\/10.1002\/1097-0142(19861015)58:8%3C1668::aid-cncr2820580816%3E3. .0.co;2-0 PubMed PMID: 3756789.","journal-title":"Cancer"},{"issue":"9","key":"3803_CR122","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/s41596-018-0022-9","volume":"13","author":"D Rodenhizer","year":"2018","unstructured":"Rodenhizer D, Dean T, Xu B, Cojocari D, McGuigan AP. A three-dimensional engineered heterogeneous tumor model for assessing cellular environment and response. Nat Protoc. 2018;13(9):1917\u201357. https:\/\/doi.org\/10.1038\/s41596-018-0022-9 . PubMed PMID: 30190554.","journal-title":"Nat Protoc"},{"key":"3803_CR123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-016-0152-x","volume":"4","author":"TH Haukaas","year":"2016","unstructured":"Haukaas TH, Euceda LR, Giske\u00f8deg\u00e5rd GF, Lamichhane S, Krohn M, Jernstr\u00f6m S, et al. Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer Metab. 2016;4:12. https:\/\/doi.org\/10.1186\/s40170-016-0152-x . PubMed PMID: 27350877; PubMed Central PMCID: PMC4922058.","journal-title":"Cancer Metab"},{"issue":"3","key":"3803_CR124","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1073\/pnas.1613855114","volume":"114","author":"F Bordeleau","year":"2017","unstructured":"Bordeleau F, Mason BN, Lollis EM, Mazzola M, Zanotelli MR, Somasegar S, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci U S A. 2017;114(3):492\u20137. https:\/\/doi.org\/10.1073\/pnas.1613855114 . PubMed PMID: 28034921; PubMed Central PMCID: PMC5255592.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3803_CR125","doi-asserted-by":"publisher","unstructured":"Chargari C, Clemenson C, Martins I, Perfettini JL, Deutsch E. Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 16(1\u20132):10\u201321. https:\/\/doi.org\/10.1016\/j.drup.2013.01.001","DOI":"10.1016\/j.drup.2013.01.001"},{"issue":"4","key":"3803_CR126","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21(4):217\u201338. https:\/\/doi.org\/10.1038\/s41568-020-00329-7 . PubMed PMID: 33589810.","journal-title":"Nat Rev Cancer"},{"key":"3803_CR127","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.004077","author":"TR Cox","year":"2011","unstructured":"Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer. DMM Disease Models Mech. 2011. https:\/\/doi.org\/10.1242\/dmm.004077.","journal-title":"DMM Disease Models Mech"},{"issue":"7","key":"3803_CR128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cell.2024","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, Andr\u00e9 F, Auwerx J, Balmain A, et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell. 2024;187(7):7. https:\/\/doi.org\/10.1016\/j.cell.2024. 02.009 PubMed PMID: 38552609.","journal-title":"Cell"},{"key":"3803_CR129","doi-asserted-by":"publisher","first-page":"1635771","DOI":"10.3389\/fimmu.2025.1635771","volume":"16","author":"G Ruan","year":"2025","unstructured":"Ruan G, Wang X, Ou H, Guo D. Cancer-associated fibroblasts: dual roles from senescence sentinels to death regulators and new dimensions in therapy. Front Immunol. 2025;16:1635771. https:\/\/doi.org\/10.3389\/fimmu.2025.1635771 . PubMed PMID: 40755775; PubMed Central PMCID: PMC12313499.","journal-title":"Front Immunol"},{"issue":"1","key":"3803_CR130","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-025-02533-1","volume":"25","author":"Z Huang","year":"2025","unstructured":"Huang Z, Chen J, Zhu T, Li J, Ng HY, Zhou Y, et al. Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications. Mol Cancer. 2025;25(1):19. https:\/\/doi.org\/10.1186\/s12943-025-02533-1 . PubMed PMID: 41413569; PubMed Central PMCID: PMC12853664.","journal-title":"Mol Cancer"},{"issue":"2","key":"3803_CR131","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cmet.2017.10.005","volume":"27","author":"H Choudhry","year":"2018","unstructured":"Choudhry H, Harris AL. Advances in Hypoxia-Inducible Factor Biology. Cell Metab. 2018;27(2):281\u201398. https:\/\/doi.org\/10.1016\/j.cmet.2017.10.005 . PubMed PMID: 29129785.","journal-title":"Cell Metab"},{"issue":"23","key":"3803_CR132","doi-asserted-by":"publisher","first-page":"e2421061122","DOI":"10.1073\/pnas.2421061122","volume":"122","author":"L Cao","year":"2025","unstructured":"Cao L, Li Z, Song J, Xia X, Zhang G, Wang H, et al. Sequential drug release system: Targeting the tumor ECM for enhanced chemotherapy efficacy. Proc Natl Acad Sci U S A. 2025;122(23):e2421061122. https:\/\/doi.org\/10.1073\/pnas.2421061122 . PubMed PMID: 40472035; PubMed Central PMCID: PMC12167967.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7886","key":"3803_CR133","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun X, Wu B, Chiang HC, Deng H, Zhang X, Xiong W, et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature. 2021;599(7886):673\u20138. https:\/\/doi.org\/10.1038\/s41586-021-04057-2 . PubMed PMID: 34732895; PubMed Central PMCID: PMC8839149.","journal-title":"Nature"},{"issue":"5","key":"3803_CR134","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/cac2","volume":"44","author":"J Mei","year":"2024","unstructured":"Mei J, Cai Y, Xu R, Li Q, Chu J, Luo Z, et al. Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade. Cancer Commun (Lond). 2024;44(5):554\u201375. https:\/\/doi.org\/10.1002\/cac2. 12538 PubMed PMID: 38507505; PubMed Central PMCID: PMC11110954.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"3803_CR135","doi-asserted-by":"publisher","first-page":"102322","DOI":"10.1016\/j.xcrm.2025.102322","volume":"6","author":"KA Khan","year":"2025","unstructured":"Khan KA, Caunt Mitzner M, Cruz-Munoz W, Li G, Himmels P, Xu P, et al. Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade. Cell Rep Med. 2025;6(9):102322. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102322 . PubMed PMID: 40925374; PubMed Central PMCID: PMC12490255.","journal-title":"Cell Rep Med"},{"issue":"2","key":"3803_CR136","doi-asserted-by":"publisher","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","volume":"1873","author":"B Piersma","year":"2020","unstructured":"Piersma B, Hayward MK, Weaver VM. Fibrosis and cancer: A strained relationship. Biochim Biophys Acta Rev Cancer. 2020;1873(2):188356. 10.1016\/j. .bbcan.2020.188356 PubMed PMID: 32147542; PubMed Central PMCID: PMC7733542.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"8","key":"3803_CR137","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2023.06.007","volume":"41","author":"HM Jeon","year":"2023","unstructured":"Jeon HM, Kim JY, Cho HJ, Lee WJ, Nguyen D, Kim SS, et al. Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling. Cancer Cell. 2023;41(8):1480\u2013e14979. https:\/\/doi.org\/10.1016\/j.ccell.2023.06.007 . PubMed PMID: 37451272; PubMed Central PMCID: PMC10530238.","journal-title":"Cancer Cell"},{"key":"3803_CR138","doi-asserted-by":"publisher","first-page":"1616943","DOI":"10.3389\/fonc.2025.1616943","volume":"15","author":"C Guerrero Quiles","year":"2025","unstructured":"Guerrero Quiles C, Fahy S, Bartak M, Gonzalez Abalos J, Powell E, Lodhi T, et al. Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer. Front Oncol. 2025;15:1616943. https:\/\/doi.org\/10.3389\/fonc.2025.1616943 . PubMed PMID: 40792276; PubMed Central PMCID: PMC12336036.","journal-title":"Front Oncol"},{"issue":"24","key":"3803_CR139","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1038\/s41388-018-0199-y","volume":"37","author":"KC Yoo","year":"2018","unstructured":"Yoo KC, Suh Y, An Y, Lee HJ, Jeong YJ, Uddin N, et al. Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation. Oncogene. 2018;37(24):3317\u201328. https:\/\/doi.org\/10.1038\/s41388-018-0199-y . PubMed PMID: 29559744.","journal-title":"Oncogene"},{"issue":"3","key":"3803_CR140","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","volume":"8","author":"MJ Paszek","year":"2005","unstructured":"Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241\u201354. https:\/\/doi.org\/10.1016\/j.ccr.2005.08.010.","journal-title":"Cancer Cell"},{"issue":"6","key":"3803_CR141","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","volume":"37","author":"Y Shen","year":"2020","unstructured":"Shen Y, Wang X, Lu J, Salfenmoser M, Wirsik NM, Schleussner N, et al. Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer. Cancer Cell. 2020;37(6):800\u2013e8177. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.005 . PubMed PMID: 32516590.","journal-title":"Cancer Cell"},{"issue":"1","key":"3803_CR142","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.stem.2023.12.002","volume":"31","author":"JJ Northey","year":"2024","unstructured":"Northey JJ, Hayward MK, Yui Y, Stashko C, Kai F, Mouw JK, et al. Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk. Cell Stem Cell. 2024;31(1):106\u2013e12613. https:\/\/doi.org\/10.1016\/j.stem.2023.12.002 . PubMed PMID: 38181747; PubMed Central PMCID: PMC11050720.","journal-title":"Cell Stem Cell"},{"issue":"36","key":"3803_CR143","doi-asserted-by":"publisher","first-page":"e2309966","DOI":"10.1002\/advs.202309966","volume":"11","author":"A Ku\u015fo\u011flu","year":"2024","unstructured":"Ku\u015fo\u011flu A, \u00d6rnek D, Dans\u0131k A, Uzun C, Nur \u00d6zkan S, Sar\u0131ca S, et al. Extracellular Matrix Sulfation in the Tumor Microenvironment Stimulates Cancer Stemness and Invasiveness. Adv Sci (Weinh). 2024;11(36):e2309966. https:\/\/doi.org\/10.1002\/advs.202309966 . PubMed PMID: 39083319; PubMed Central PMCID: PMC11423251.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"3803_CR144","doi-asserted-by":"publisher","first-page":"113175","DOI":"10.1016\/j.celrep.2023.113175","volume":"42","author":"A Sohrabi","year":"2023","unstructured":"Sohrabi A, Lefebvre AEYT, Harrison MJ, Condro MC, Sanazzaro TM, Safarians G, et al. Microenvironmental stiffness induces metabolic reprogramming in glioblastoma. Cell Rep. 2023;42(10):113175. https:\/\/doi.org\/10.1016\/j.celrep.2023.113175 . PubMed PMID: 37756163; PubMed Central PMCID: PMC10842372.","journal-title":"Cell Rep"},{"issue":"1","key":"3803_CR145","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41419-025-08222-7","volume":"16","author":"Y Tao","year":"2025","unstructured":"Tao Y, Huang J, Hou J, Hu Z, Zhang T, Mo Z, et al. Matrix stiffness maintains bladder cancer stemness via integrin-nuclear skeleton axis. Cell Death Dis. 2025;16(1):887. https:\/\/doi.org\/10.1038\/s41419-025-08222-7 . PubMed PMID: 41387479; PubMed Central PMCID: PMC12700999.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3803_CR146","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4082","volume":"22","author":"H Laklai","year":"2016","unstructured":"Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS, et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med. 2016;22(5):497\u2013505. https:\/\/doi.org\/10.1038\/nm.4082 . PubMed PMID: 27089513; PubMed Central PMCID: PMC4860133.","journal-title":"Nat Med"},{"issue":"6","key":"3803_CR147","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15(6):637\u201346. https:\/\/doi.org\/10.1038\/ncb2756 . PubMed PMID: 23708000; PubMed Central PMCID: PMC3836234.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3803_CR148","doi-asserted-by":"publisher","first-page":"e10698","DOI":"10.1002\/btm2","volume":"10","author":"X Zhang","year":"2025","unstructured":"Zhang X, Al-Danakh A, Zhu X, Feng D, Yang L, Wu H, et al. Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer. Bioeng Transl Med. 2025;10(1):e10698. https:\/\/doi.org\/10.1002\/btm2. 10698 PubMed PMID: 39801760; PubMed Central PMCID: PMC11711218.","journal-title":"Bioeng Transl Med"},{"issue":"10","key":"3803_CR149","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1039\/c5ib00040h","volume":"7","author":"I Acerbi","year":"2015","unstructured":"Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C, et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol (Camb). 2015;7(10):1120\u201334. https:\/\/doi.org\/10.1039\/c5ib00040h . PubMed PMID: 25959051; PubMed Central PMCID: PMC4593730.","journal-title":"Integr Biol (Camb)"},{"issue":"3","key":"3803_CR150","doi-asserted-by":"publisher","first-page":"031901","DOI":"10.1063\/1.5018327","volume":"2","author":"JP Miller","year":"2018","unstructured":"Miller JP, Borde BH, Bordeleau F, Zanotelli MR, LaValley DJ, Parker DJ, et al. Clinical doses of radiation reduce collagen matrix stiffness. APL Bioeng. 2018;2(3):031901. https:\/\/doi.org\/10.1063\/1.5018327 . PubMed PMID: 31069314; PubMed Central PMCID: PMC6324208.","journal-title":"APL Bioeng"},{"issue":"11","key":"3803_CR151","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","volume":"141","author":"JM Straub","year":"2015","unstructured":"Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141(11):1985\u201394. https:\/\/doi.org\/10.1007\/s00432-015-1974-6 . PubMed PMID: 25910988; PubMed Central PMCID: PMC4573901.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3803_CR152","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1186\/s12967-023-04554-0","volume":"21","author":"Z Yu","year":"2023","unstructured":"Yu Z, Xu C, Song B, Zhang S, Chen C, Li C, et al. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. J Transl Med. 2023;21(1):708. https:\/\/doi.org\/10.1186\/s12967-023-04554-0 . PubMed PMID: 37814303; PubMed Central PMCID: PMC10563272.","journal-title":"J Transl Med"},{"key":"3803_CR153","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pnmrs.2015.06","volume":"90\u201391","author":"KM Pepin","year":"2015","unstructured":"Pepin KM, Ehman RL, McGee KP. Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications. Prog Nucl Magn Reson Spectrosc. 2015;90\u201391:32\u201348. https:\/\/doi.org\/10.1016\/j.pnmrs.2015.06. .001 PubMed PMID: 26592944; PubMed Central PMCID: PMC4660259.","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"issue":"8","key":"3803_CR154","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/RLI.0000000000000971","volume":"58","author":"J Guo","year":"2023","unstructured":"Guo J, Savic LJ, Hillebrandt KH, Sack I. MR Elastography in Cancer. Invest Radiol. 2023;58(8):578\u201386. 10. 1097\/RLI.0000000000000971 PubMed PMID: 36897804.","journal-title":"Invest Radiol"},{"issue":"11","key":"3803_CR155","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.21037\/tau-2025-495","volume":"14","author":"S Chapain","year":"2025","unstructured":"Chapain S, Yadav DK, Ren Z, Chen A, Sun S, Wang R, et al. Magnetic resonance elastography for prostate cancer: advancing diagnostic accuracy, tumor characterization, and clinical applications. Transl Androl Urol. 2025;14(11):3771\u201381. https:\/\/doi.org\/10.21037\/tau-2025-495 . PubMed PMID: 41368237; PubMed Central PMCID: PMC12683485.","journal-title":"Transl Androl Urol"},{"key":"3803_CR156","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/(SICI)1097-4644(1998)72:30\/31+<250::AID-JCB31>3.0.CO;2-3","volume":"30\u201331","author":"SA Leli\u00e8vre","year":"1998","unstructured":"Leli\u00e8vre SA, Bissell MJ. Communication between the cell membrane and the nucleus: role of protein compartmentalization. J Cell Biochem Suppl. 1998;30\u201331:250\u201363. PubMed PMID: 9893278; PubMed Central PMCID: PMC2933207.","journal-title":"J Cell Biochem Suppl"},{"key":"3803_CR157","doi-asserted-by":"publisher","first-page":"885859","DOI":"10.3389\/fcell.2022.885859","volume":"10","author":"N Ueda","year":"2022","unstructured":"Ueda N, Maekawa M, Matsui TS, Deguchi S, Takata T, Katahira J, et al. Inner Nuclear Membrane Protein, SUN1, is Required for Cytoskeletal Force Generation and Focal Adhesion Maturation. Front Cell Dev Biol. 2022;10:885859. https:\/\/doi.org\/10.3389\/fcell.2022.885859 . PubMed PMID: 35663386; PubMed Central PMCID: PMC9157646.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"3803_CR158","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.biocel.2010.07.001","volume":"42","author":"M Brosig","year":"2010","unstructured":"Brosig M, Ferralli J, Gelman L, Chiquet M, Chiquet-Ehrismann R. Interfering with the connection between the nucleus and the cytoskeleton affects nuclear rotation, mechanotransduction and myogenesis. Int J Biochem Cell Biol. 2010;42(10):1717\u201328. .001 PubMed PMID: 20621196.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"3803_CR159","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41419-021-03728-2","volume":"12","author":"YH Wang","year":"2021","unstructured":"Wang YH, Guo Z, An L, Zhou Y, Xu H, Xiong J, et al. LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer. Cell Death Dis. 2021;12(5):454. https:\/\/doi.org\/10.1038\/s41419-021-03728-2 . PubMed PMID: 33963177; PubMed Central PMCID: PMC8105365.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3803_CR160","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41419-020-02977-x","volume":"11","author":"J Zheng","year":"2020","unstructured":"Zheng J, Wang B, Zheng R, Zhang J, Huang C, Zheng R, et al. Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1\/USP44 combination in glioma cells. Cell Death Dis. 2020;11(9):758. https:\/\/doi.org\/10.1038\/s41419-020-02977-x . PubMed PMID: 32934196; PubMed Central PMCID: PMC7492255.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3803_CR161","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tcb.2020","volume":"31","author":"PM Davidson","year":"2021","unstructured":"Davidson PM, Cadot B. Actin on and around the Nucleus. Trends Cell Biol. 2021;31(3):211\u201323. https:\/\/doi.org\/10.1016\/j.tcb.2020. 11.009 PubMed PMID: 33376040.","journal-title":"Trends Cell Biol"},{"key":"3803_CR162","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.semcdb.2013","volume":"29","author":"S Cartwright","year":"2014","unstructured":"Cartwright S, Karakesisoglou I. Nesprins in health and disease. Semin Cell Dev Biol. 2014;29:169\u201379. https:\/\/doi.org\/10.1016\/j.semcdb.2013. 12.010 PubMed PMID: 24374011.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"3803_CR163","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/19491034","volume":"6","author":"C Guilluy","year":"2015","unstructured":"Guilluy C, Burridge K. Nuclear mechanotransduction: forcing the nucleus to respond. Nucleus. 2015;6(1):19\u201322. https:\/\/doi.org\/10.1080\/19491034. 2014.1001705 PubMed PMID: 25738642; PubMed Central PMCID: PMC4615784.","journal-title":"Nucleus"},{"issue":"1","key":"3803_CR164","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4161\/nucl.1","volume":"1","author":"A M\u00e9jat","year":"2010","unstructured":"M\u00e9jat A, Misteli T. LINC complexes in health and disease. Nucleus. 2010;1(1):40\u201352. https:\/\/doi.org\/10.4161\/nucl.1. .1.10530 PubMed PMID: 21327104; PubMed Central PMCID: PMC3035119.","journal-title":"Nucleus"},{"issue":"6","key":"3803_CR165","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1042\/BST20110669","volume":"39","author":"M Ketema","year":"2011","unstructured":"Ketema M, Sonnenberg A. Nesprin-3: a versatile connector between the nucleus and the cytoskeleton. Biochem Soc Trans. 2011;39(6):1719\u201324. doi:10.1042\/BST20110669 PubMed PMID: 22103514.","journal-title":"Biochem Soc Trans"},{"key":"3803_CR166","doi-asserted-by":"publisher","first-page":"1631645","DOI":"10.3389\/fmed.2025.1631645","volume":"12","author":"S Yang","year":"2025","unstructured":"Yang S, Liu H, Chen B, Kou H, Lai L, Zhang X, et al. Mechanical signal-chromatin interactions: molecular networks from nuclear membrane force transmission to epigenetic regulation. Front Med (Lausanne). 2025;12:1631645. https:\/\/doi.org\/10.3389\/fmed.2025.1631645 . PubMed PMID: 41140684; PubMed Central PMCID: PMC12546022.","journal-title":"Front Med (Lausanne)"},{"key":"3803_CR167","doi-asserted-by":"publisher","unstructured":"Vinayak V, Lakadamyali M, Shenoy VB. Architecture and regulation of nanoscale chromatin domains. Nat Commun. 2026 Apr;1. https:\/\/doi.org\/10.1038\/s41467-026-71213-5 . PubMed PMID: 41922325.","DOI":"10.1038\/s41467-026-71213-5"},{"issue":"11","key":"3803_CR168","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol. 2014;15(11):703\u20138. https:\/\/doi.org\/10.1038\/nrm3890 . PubMed PMID: 25315270.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3803_CR169","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.physiol.59.1","volume":"59","author":"DE Ingber","year":"1997","unstructured":"Ingber DE. Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol. 1997;59:575\u201399. https:\/\/doi.org\/10.1146\/annurev.physiol.59.1. .575 PubMed PMID: 9074778.","journal-title":"Annu Rev Physiol"},{"key":"3803_CR170","first-page":"417","volume":"51","author":"S Leli\u00e8vre","year":"1996","unstructured":"Leli\u00e8vre S, Weaver VM, Bissell MJ. Extracellular matrix signaling from the cellular membrane skeleton to the nuclear skeleton: a model of gene regulation. Recent Prog Horm Res. 1996;51:417\u201332. PubMed PMID: 8701089; PubMed Central PMCID: PMC2937008.","journal-title":"Recent Prog Horm Res"},{"issue":"9","key":"3803_CR171","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.bbagen.2009.03.013","volume":"1790","author":"SA Leli\u00e8vre","year":"2009","unstructured":"Leli\u00e8vre SA. Contributions of extracellular matrix signaling and tissue architecture to nuclear mechanisms and spatial organization of gene expression control. Biochim Biophys Acta. 2009;1790(9):925\u201335. https:\/\/doi.org\/10.1016\/j.bbagen.2009.03.013 . PubMed PMID: 19328836; PubMed Central PMCID: PMC2728154.","journal-title":"Biochim Biophys Acta"},{"key":"3803_CR172","doi-asserted-by":"crossref","unstructured":"Packirisamy S, Andr\u00e9 O, Fan Z, Nordenfelt P, Swaminathan VS. ECM-Stiffness Mediated Persistent Fibroblast Activation Requires Integrin and Formin Dependent Chromatin Remodeling. Adv Sci (Weinh). 2026. e17631. PubMed PMID: 41915876.","DOI":"10.1101\/2025.09.16.676527"},{"issue":"8","key":"3803_CR173","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00109","volume":"95","author":"JM Spangle","year":"2017","unstructured":"Spangle JM, Roberts TM. Epigenetic regulation of RTK signaling. J Mol Med (Berl). 2017;95(8):791\u20138. https:\/\/doi.org\/10.1007\/s00109-. 017-1546-0 PubMed PMID: 28589435; PubMed Central PMCID: PMC5663182.","journal-title":"J Mol Med (Berl)"},{"issue":"14","key":"3803_CR174","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1016\/j.yexcr.2007.04.022","volume":"313","author":"J Le Beyec","year":"2007","unstructured":"Le Beyec J, Xu R, Lee SY, Nelson CM, Rizki A, Alcaraz J, et al. Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp Cell Res. 2007;313(14):3066\u201375. https:\/\/doi.org\/10.1016\/j.yexcr.2007.04.022 . PubMed PMID: 17524393; PubMed Central PMCID: PMC2040058.","journal-title":"Exp Cell Res"},{"key":"3803_CR175","doi-asserted-by":"publisher","first-page":"102405","DOI":"10.1016\/j.ceb.2024.102405","volume":"90","author":"JA Downs","year":"2024","unstructured":"Downs JA, Gasser SM. Chromatin remodeling and spatial concerns in DNA double-strand break repair. Curr Opin Cell Biol. 2024;90:102405. https:\/\/doi.org\/10.1016\/j.ceb.2024.102405 . PubMed PMID: 39083951.","journal-title":"Curr Opin Cell Biol"},{"issue":"10","key":"3803_CR176","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.tcb.2021","volume":"31","author":"N Lamm","year":"2021","unstructured":"Lamm N, Rogers S, Cesare AJ. Chromatin mobility and relocation in DNA repair. Trends Cell Biol. 2021;31(10):843\u201355. https:\/\/doi.org\/10.1016\/j.tcb.2021. 06.002 PubMed PMID: 34183232.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"3803_CR177","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12943-025-02433-4","volume":"24","author":"FY Zhao","year":"2025","unstructured":"Zhao FY, Shi LY, Yu LJ, Wang SQ, Sun CY, Zhang N, et al. Decoding the ubiquitin network: molecular mechanisms and therapeutic vulnerabilities for precision radio-sensitization in cancer. Mol Cancer. 2025;24(1):233. https:\/\/doi.org\/10.1186\/s12943-025-02433-4 . PubMed PMID: 41039553; PubMed Central PMCID: PMC12492556.","journal-title":"Mol Cancer"},{"key":"3803_CR178","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/bs.ircmb.2023","volume":"383","author":"E Arechaga-Ocampo","year":"2024","unstructured":"Arechaga-Ocampo E. Epigenetics as a determinant of radiation response in cancer. Int Rev Cell Mol Biol. 2024;383:145\u201390. https:\/\/doi.org\/10.1016\/bs.ircmb.2023. 07.008 PubMed PMID: 38359968.","journal-title":"Int Rev Cell Mol Biol"},{"key":"3803_CR179","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biocel.2014.01","volume":"49","author":"C Lavelle","year":"2014","unstructured":"Lavelle C, Foray N. Chromatin structure and radiation-induced DNA damage: from structural biology to radiobiology. Int J Biochem Cell Biol. 2014;49:84\u201397. https:\/\/doi.org\/10.1016\/j.biocel.2014.01. .012 PubMed PMID: 24486235.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"3803_CR180","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/1535-7163.MCT-18-1320","volume":"19","author":"N Gomez-Roman","year":"2020","unstructured":"Gomez-Roman N, Chong MY, Chahal SK, Caragher SP, Jackson MR, Stevenson KH, et al. Radiation Responses of 2D and 3D Glioblastoma Cells: A Novel, 3D-specific Radioprotective Role of VEGF\/Akt Signaling through Functional Activation of NHEJ. Mol Cancer Ther. 2020;19(2):575\u201389. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-1320 . PubMed PMID: 31672763.","journal-title":"Mol Cancer Ther"},{"issue":"37","key":"3803_CR181","doi-asserted-by":"publisher","first-page":"eabb2630","DOI":"10.1126\/sciadv.abb2630","volume":"6","author":"M Deng","year":"2020","unstructured":"Deng M, Lin J, Nowsheen S, Liu T, Zhao Y, Villalta PW, et al. Extracellular matrix stiffness determines DNA repair efficiency and cellular sensitivity to genotoxic agents. Sci Adv. 2020;6(37):eabb2630. https:\/\/doi.org\/10.1126\/sciadv.abb2630 . PubMed PMID: 32917705; PubMed Central PMCID: PMC7486107.","journal-title":"Sci Adv"},{"key":"3803_CR182","first-page":"319287","volume":"2012","author":"K Storch","year":"2012","unstructured":"Storch K, Cordes N. Focal adhesion-chromatin linkage controls tumor cell resistance to radio- and chemotherapy. Chemother Res Pract. 2012;2012:319287. doi:10.1155\/2012\/319287 PubMed PMID: 22778951; PubMed Central PMCID: PMC3385588.","journal-title":"Chemother Res Pract"},{"issue":"1","key":"3803_CR183","doi-asserted-by":"publisher","first-page":"28054","DOI":"10.1038\/s41598-025-11807-z","volume":"15","author":"JM Gray","year":"2025","unstructured":"Gray JM, Park WY, Holewinski RJ, Andresson T, Carmona-Rivera C, Kaplan MJ, et al. Proteomic analysis of tumor cell nuclear expulsion reveals significant cell adhesion and RNA binding programs in extracellular chromatin. Sci Rep. 2025;15(1):28054. https:\/\/doi.org\/10.1038\/s41598-025-11807-z . PubMed PMID: 40751052; PubMed Central PMCID: PMC12317086.","journal-title":"Sci Rep"},{"key":"3803_CR184","doi-asserted-by":"publisher","first-page":"102376","DOI":"10.1016\/j.ceb.2024.102376","volume":"88","author":"M Vivo","year":"2024","unstructured":"Vivo M, Rosti V, Cervone S, Lanzuolo C. Chromatin plasticity in mechanotransduction. Curr Opin Cell Biol. 2024;88:102376. https:\/\/doi.org\/10.1016\/j.ceb.2024.102376 . PubMed PMID: 38810318.","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"3803_CR185","doi-asserted-by":"publisher","first-page":"JCS263615","DOI":"10.1242\/jcs.263615","volume":"138","author":"J Morival","year":"2025","unstructured":"Morival J, Hazelwood A, Lammerding J. Feeling the force from within - new tools and insights into nuclear mechanotransduction. J Cell Sci. 2025;138(5):JCS263615. https:\/\/doi.org\/10.1242\/jcs.263615 . PubMed PMID: 40059756; PubMed Central PMCID: PMC11959624.","journal-title":"J Cell Sci"},{"issue":"2","key":"3803_CR186","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1111\/boc.70052","volume":"118","author":"Y Shetty","year":"2026","unstructured":"Shetty Y, Dolega ME. Mechanobiology of the Nucleolus. Biol Cell. 2026;118(2):e70052. https:\/\/doi.org\/10.1111\/boc.70052 . PubMed PMID: 41761918; PubMed Central PMCID: PMC12949487.","journal-title":"Biol Cell"},{"issue":"2","key":"3803_CR187","doi-asserted-by":"publisher","first-page":"021503","DOI":"10.1063\/5.0255473","volume":"9","author":"Y Yokoyama","year":"2025","unstructured":"Yokoyama Y, Domkam N, Kabir H, Mansour A, Tsukamoto S, Yerima G, et al. Emerging mechanomedicines informed by mechanotransduction along the integrin-cytoskeleton-nucleus axis. APL Bioeng. 2025;9(2):021503. https:\/\/doi.org\/10.1063\/5.0255473 . PubMed PMID: 40502441; PubMed Central PMCID: PMC12158467.","journal-title":"APL Bioeng"},{"issue":"6","key":"3803_CR188","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.devcel.2019.04.020","volume":"49","author":"S Cho","year":"2019","unstructured":"Cho S, Vashisth M, Abbas A, Majkut S, Vogel K, Xia Y, et al. Mechanosensing by the Lamina Protects against Nuclear Rupture, DNA Damage, and Cell-Cycle Arrest. Dev Cell. 2019;49(6):920\u2013e9355. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.020 . PubMed PMID: 31105008; PubMed Central PMCID: PMC6581604.","journal-title":"Dev Cell"},{"issue":"20","key":"3803_CR189","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1016\/j.molcel.2023.09.023","volume":"83","author":"MT Kovacs","year":"2023","unstructured":"Kovacs MT, Vallette M, Wiertsema P, Dingli F, Loew D, de Nader GP. DNA damage induces nuclear envelope rupture through ATR-mediated phosphorylation of lamin A\/C. Mol Cell. 2023;83(20):3659\u2013e366810. https:\/\/doi.org\/10.1016\/j.molcel.2023.09.023 . PubMed PMID: 37832547; PubMed Central PMCID: PMC10597398.","journal-title":"Mol Cell"},{"key":"3803_CR190","doi-asserted-by":"publisher","first-page":"151639","DOI":"10.1016\/j.bbrc.2025.151639","volume":"758","author":"I Ali","year":"2025","unstructured":"Ali I, Xu F, Peng Q, Qiu J. The dilemma of nuclear mechanical forces in DNA damage and repair. Biochem Biophys Res Commun. 2025;758:151639. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151639 . PubMed PMID: 40121966.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"3803_CR191","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/embor.2013.49","volume":"14","author":"HB Schiller","year":"2013","unstructured":"Schiller HB, F\u00e4ssler R. Mechanosensitivity and compositional dynamics of cell-matrix adhesions. EMBO Rep. 2013;14(6):509\u201319. https:\/\/doi.org\/10.1038\/embor.2013.49.","journal-title":"EMBO Rep"},{"key":"3803_CR192","doi-asserted-by":"publisher","unstructured":"Agarwal P, Raman R, Agarwal P, Prabhu V, Kumar P. Integrins in cancer: insights into mechanisms and therapeutic potential. Cell Commun Signal. 2026 Mar;27. https:\/\/doi.org\/10.1186\/s12964-026-. 02828-w PubMed PMID: 41888835.","DOI":"10.1186\/s12964-026-"},{"issue":"3","key":"3803_CR193","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/jcp.21278","volume":"213","author":"N Alam","year":"2007","unstructured":"Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, et al. The integrin-growth factor receptor duet. J Cell Physiol. 2007;213(3):649\u201353. https:\/\/doi.org\/10.1002\/jcp.21278 . PubMed PMID: 17886260.","journal-title":"J Cell Physiol"},{"key":"3803_CR194","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.semcdb.2018","volume":"89","author":"AM Socovich","year":"2019","unstructured":"Socovich AM, Naba A. The cancer matrisome: From comprehensive characterization to biomarker discovery. Semin Cell Dev Biol. 2019;89:157\u201366. https:\/\/doi.org\/10.1016\/j.semcdb.2018. 06.005 PubMed PMID: 29964200.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"3803_CR195","doi-asserted-by":"publisher","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","volume":"4","author":"RO Hynes","year":"2012","unstructured":"Hynes RO, Naba A. Overview of the matrisome\u2013an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. 2012;4(1):a004903. https:\/\/doi.org\/10.1101\/cshperspect.a004903 . PubMed PMID: 21937732; PubMed Central PMCID: PMC3249625.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"3803_CR196","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrm2594","volume":"10","author":"N Wang","year":"2009","unstructured":"Wang N, Tytell JD, Ingber DE. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol. 2009;10(1):75\u201382. https:\/\/doi.org\/10.1038\/nrm2594 . PubMed PMID: 19197334.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"25","key":"3803_CR197","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.1073\/pnas.95.25","volume":"95","author":"F Wang","year":"1998","unstructured":"Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A. 1998;95(25):14821\u20136. https:\/\/doi.org\/10.1073\/pnas.95.25. .14821 PubMed PMID: 9843973; PubMed Central PMCID: PMC24533.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3803_CR198","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-bioeng-071114","volume":"17","author":"JM Phillip","year":"2015","unstructured":"Phillip JM, Aifuwa I, Walston J, Wirtz D. The Mechanobiology of Aging. Annu Rev Biomed Eng. 2015;17:113\u201341. https:\/\/doi.org\/10.1146\/annurev-bioeng-071114. -040829 PubMed PMID: 26643020; PubMed Central PMCID: PMC4886230.","journal-title":"Annu Rev Biomed Eng"},{"issue":"3","key":"3803_CR199","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41577-022-00761","volume":"23","author":"H Du","year":"2023","unstructured":"Du H, Bartleson JM, Butenko S, Alonso V, Liu WF, Winer DA, et al. Tuning immunity through tissue mechanotransduction. Nat Rev Immunol. 2023;23(3):174\u201388. https:\/\/doi.org\/10.1038\/s41577-022-00761-. w PubMed PMID: 35974148; PubMed Central PMCID: PMC9379893.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3803_CR200","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00018","volume":"81","author":"DN Alasaadi","year":"2024","unstructured":"Alasaadi DN, Mayor R. Mechanically guided cell fate determination in early development. Cell Mol Life Sci. 2024;81(1):242. https:\/\/doi.org\/10.1007\/s00018-. 024-05272-6 PubMed PMID: 38811420; PubMed Central PMCID: PMC11136904.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3803_CR201","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon J, Bakhoum SF. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer. Cancer Discov. 2020;10(1):26\u201339. https:\/\/doi.org\/10.1158\/2159-8290. .CD-19-0761 PubMed PMID: 31852718; PubMed Central PMCID: PMC7151642.","journal-title":"Cancer Discov"},{"issue":"14","key":"3803_CR202","doi-asserted-by":"publisher","first-page":"jcs261723","DOI":"10.1242\/jcs.261723","volume":"137","author":"DD Schlaepfer","year":"2024","unstructured":"Schlaepfer DD, Ojalill M, Stupack DG. Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities. J Cell Sci. 2024;137(14):jcs261723. https:\/\/doi.org\/10.1242\/jcs.261723 . PubMed PMID: 39034922; PubMed Central PMCID: PMC11298715.","journal-title":"J Cell Sci"},{"key":"3803_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2593","author":"B Geiger","year":"2009","unstructured":"Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol. 2009. https:\/\/doi.org\/10.1038\/nrm2593.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"3803_CR204","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00109-020-02026-2","volume":"99","author":"H Maldonado","year":"2021","unstructured":"Maldonado H, Hagood JS. Cooperative signaling between integrins and growth factor receptors in fibrosis. J Mol Med (Berl). 2021;99(2):213\u201324. https:\/\/doi.org\/10.1007\/s00109-020-02026-2 . PubMed PMID: 33392631.","journal-title":"J Mol Med (Berl)"},{"issue":"41","key":"3803_CR205","doi-asserted-by":"publisher","first-page":"E8685","DOI":"10.1073\/pnas.1701821114","volume":"114","author":"A Jahangiri","year":"2017","unstructured":"Jahangiri A, Nguyen A, Chandra A, Sidorov MK, Yagnik G, Rick J, et al. Cross-activating c-Met\/\u03b21 integrin complex drives metastasis and invasive resistance in cancer. Proc Natl Acad Sci U S A. 2017;114(41):E8685\u201394. https:\/\/doi.org\/10.1073\/pnas.1701821114 . PubMed PMID: 28973887; PubMed Central PMCID: PMC5642678.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3803_CR206","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nrc2967","volume":"10","author":"S Cabodi","year":"2010","unstructured":"Cabodi S, del Pilar Camacho-Leal M, Di Stefano P, Defilippi P. Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer. 2010;10(12):858\u201370. https:\/\/doi.org\/10.1038\/nrc2967 . PubMed PMID: 21102636.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3803_CR207","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1172\/JCI41078","volume":"120","author":"I Eke","year":"2010","unstructured":"Eke I, Koch U, Hehlgans S, Sandfort V, Stanchi F, Zips D, et al. PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha. J Clin Investig. 2010;120(7):2516\u201327. https:\/\/doi.org\/10.1172\/JCI41078.","journal-title":"J Clin Investig"},{"issue":"1","key":"3803_CR208","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ccell.2018.11.016","volume":"35","author":"M Shen","year":"2019","unstructured":"Shen M, Jiang YZ, Wei Y, Ell B, Sheng X, Esposito M, et al. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin\/FAK and EGFR Signaling. Cancer Cell. 2019;35(1):64\u2013e807. https:\/\/doi.org\/10.1016\/j.ccell.2018.11.016 . PubMed PMID: 30612941.","journal-title":"Cancer Cell"},{"issue":"8","key":"3803_CR209","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1158\/1541-7786.MCR-11-0600","volume":"10","author":"JO Nam","year":"2012","unstructured":"Nam JO, Son HN, Jun E, Cha K, Lee BH, Park RW, et al. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and \u03b1v\u03b23 integrin. Mol Cancer Res. 2012;10(8):1010\u201320. https:\/\/doi.org\/10.1158\/1541-7786.MCR-11-0600 . PubMed PMID: 22710795.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"3803_CR210","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10456-009-9141-9","volume":"12","author":"PR Somanath","year":"2009","unstructured":"Somanath PR, Malinin NL, Byzova TV. Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis. 2009;12(2):177\u201385. https:\/\/doi.org\/10.1007\/s10456-009-9141-9 . PubMed PMID: 19267251; PubMed Central PMCID: PMC2863048.","journal-title":"Angiogenesis"},{"issue":"5","key":"3803_CR211","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ijc.25134","volume":"127","author":"C Chetty","year":"2010","unstructured":"Chetty C, Lakka SS, Bhoopathi P, Rao JS. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K\/AKT signaling in A549 lung cancer cells. Int J Cancer. 2010;127(5):1081\u201395. https:\/\/doi.org\/10.1002\/ijc.25134 . PubMed PMID: 20027628; PubMed Central PMCID: PMC2891576.","journal-title":"Int J Cancer"},{"issue":"18","key":"3803_CR212","doi-asserted-by":"publisher","first-page":"e2102171118","DOI":"10.1073\/pnas.2102171118","volume":"118","author":"R Datta","year":"2021","unstructured":"Datta R, Lizama CO, Soltani AK, Mckleroy W, Podolsky MJ, Yang CD, et al. Autoregulation of insulin receptor signaling through MFGE8 and the \u03b1v\u03b25 integrin. Proc Natl Acad Sci U S A. 2021;118(18):e2102171118. https:\/\/doi.org\/10.1073\/pnas.2102171118 . PubMed PMID: 33903257; PubMed Central PMCID: PMC8106306.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3803_CR213","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1158\/0008-5472.CAN-08-3612","volume":"69","author":"JM Ricono","year":"2009","unstructured":"Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, et al. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer Res. 2009;69(4):1383\u201391. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3612 . PubMed PMID: 19208836; PubMed Central PMCID: PMC2741736.","journal-title":"Cancer Res"},{"issue":"45","key":"3803_CR214","doi-asserted-by":"publisher","first-page":"27228","DOI":"10.1074\/jbc.M","volume":"290","author":"BL Carpenter","year":"2015","unstructured":"Carpenter BL, Chen M, Knifley T, Davis KA, Harrison SMW, Stewart RL, et al. Integrin \u03b16\u03b24 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF). J Biol Chem. 2015;290(45):27228\u201338. https:\/\/doi.org\/10.1074\/jbc.M. 115.686873 PubMed PMID: 26381405; PubMed Central PMCID: PMC4646402.","journal-title":"J Biol Chem"},{"issue":"9","key":"3803_CR215","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1093\/emboj\/16.9.2365","volume":"16","author":"F Mainiero","year":"1997","unstructured":"Mainiero F, Murgia C, Wary KK, Curatola AM, Pepe A, Blumemberg M, et al. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J. 1997;16(9):2365\u201375. https:\/\/doi.org\/10.1093\/emboj\/16.9.2365 . PubMed PMID: 9171350; PubMed Central PMCID: PMC1169837.","journal-title":"EMBO J"},{"issue":"3","key":"3803_CR216","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1042\/BJ20081948","volume":"418","author":"CH Streuli","year":"2009","unstructured":"Streuli CH, Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem J. 2009;418(3):491\u2013506. doi:10.1042\/BJ20081948 PubMed PMID: 19228122.","journal-title":"Biochem J"},{"key":"3803_CR217","doi-asserted-by":"publisher","unstructured":"Estrugo D, Fischer A, Hess F, Scherthan H, Belka C, Cordes N. Ligand bound \u03b21 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells. PLoS ONE. 2007;2(3). https:\/\/doi.org\/10.1371\/journal.pone.0000269.","DOI":"10.1371\/journal.pone.0000269"},{"key":"3803_CR218","doi-asserted-by":"crossref","unstructured":"Damiano JS, Hazlehurst LA, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR\/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia. 2001.","DOI":"10.1038\/sj.leu.2402179"},{"issue":"38","key":"3803_CR219","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/sj.onc.1203782","volume":"19","author":"LA Hazlehurst","year":"2000","unstructured":"Hazlehurst LA, Damiano JS, Buyuksal I, Pledger WJ, Dalton WS. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene. 2000;19(38):4319\u201327. https:\/\/doi.org\/10.1038\/sj.onc.1203782.","journal-title":"Oncogene"},{"issue":"9","key":"3803_CR220","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41419-018-0853-x","volume":"9","author":"A Kowalski-Chauvel","year":"2018","unstructured":"Kowalski-Chauvel A, Modesto A, Gouaze-Andersson V, Baricault L, Gilhodes J, Delmas C, et al. Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1. Cell Death Dis. 2018;9(9):872. https:\/\/doi.org\/10.1038\/s41419-018-0853-x . PubMed PMID: 30158599; PubMed Central PMCID: PMC6115442.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3803_CR221","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1073\/pnas.062698499","volume":"99","author":"JM Lewis","year":"2002","unstructured":"Lewis JM, Truong TN, Schwartz MA. Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci U S A. 2002;99(6):3627\u201332. https:\/\/doi.org\/10.1073\/pnas.062698499 . PubMed PMID: 11904424; PubMed Central PMCID: PMC122574.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3803_CR222","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.radonc.2012.05.009","volume":"104","author":"I Eke","year":"2012","unstructured":"Eke I, Dickreuter E, Cordes N. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by \u03b21 integrin inhibition. Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol. 2012;104(2):235\u201342. https:\/\/doi.org\/10.1016\/j.radonc.2012.05.009.","journal-title":"Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol"},{"key":"3803_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.09.007","author":"S Hehlgans","year":"2008","unstructured":"Hehlgans S, Eke I, Deuse Y, Cordes N. Integrin-linked kinase: dispensable for radiation survival of three-dimensionally cultured fibroblasts. Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol. 2008. https:\/\/doi.org\/10.1016\/j.radonc.2007.09.007.","journal-title":"Radiotherapy oncology: J Eur Soc Therapeutic Radiol Oncol"},{"key":"3803_CR224","doi-asserted-by":"publisher","unstructured":"Sandfort V, Eke I, Cordes N. The role of the focal adhesion protein PINCH1 for the radiosensitivity of adhesion and suspension cell cultures. PLoS ONE. 2010;5(9). https:\/\/doi.org\/10.1371\/journal.pone.0013056.","DOI":"10.1371\/journal.pone.0013056"},{"issue":"11","key":"3803_CR225","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41580-024-00773-5","volume":"25","author":"B Xiao","year":"2024","unstructured":"Xiao B. Mechanisms of mechanotransduction and physiological roles of PIEZO channels. Nat Rev Mol Cell Biol. 2024;25(11):886\u2013903. https:\/\/doi.org\/10.1038\/s41580-024-00773-5 . PubMed PMID: 39251883.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3803_CR226","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ceb.2020.10.008","volume":"68","author":"MA Del Pozo","year":"2021","unstructured":"Del Pozo MA, Lolo FN, Echarri A, Caveolae. Mechanosensing and mechanotransduction devices linking membrane trafficking to mechanoadaptation. Curr Opin Cell Biol. 2021;68:113\u201323. https:\/\/doi.org\/10.1016\/j.ceb.2020.10.008 . PubMed PMID: 33188985.","journal-title":"Curr Opin Cell Biol"},{"key":"3803_CR227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2023.05.001","volume":"121","author":"L Zhu","year":"2023","unstructured":"Zhu L, Liu L, Wang A, Liu J, Huang X, Zan T. Positive feedback loops between fibroblasts and the mechanical environment contribute to dermal fibrosis. Matrix Biol. 2023;121:1\u201321. https:\/\/doi.org\/10.1016\/j.matbio.2023.05.001 . PubMed PMID: 37164179.","journal-title":"Matrix Biol"},{"issue":"1","key":"3803_CR228","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41580-020-00306","volume":"22","author":"P Romani","year":"2021","unstructured":"Romani P, Valcarcel-Jimenez L, Frezza C, Dupont S. Crosstalk between mechanotransduction and metabolism. Nat Rev Mol Cell Biol. 2021;22(1):22\u201338. https:\/\/doi.org\/10.1038\/s41580-020-00306. -w PubMed PMID: 33188273.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3803_CR229","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fcell","volume":"6","author":"S Chittiboyina","year":"2018","unstructured":"Chittiboyina S, Bai Y, Leli\u00e8vre SA. Microenvironment-Cell Nucleus Relationship in the Context of Oxidative Stress. Front Cell Dev Biol. 2018;6:23. https:\/\/doi.org\/10.3389\/fcell. 2018.00023 PubMed PMID: 29594114; PubMed Central PMCID: PMC5854663.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"3803_CR230","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3109\/02841869709001322","volume":"36","author":"AF Stevenson","year":"1997","unstructured":"Stevenson AF, Lange CS. Extracellular matrix (ECM) and cytoskeletal modulation of cellular radiosensitivity. Acta Oncol. 1997;36(6):599\u2013606. doi:10.3109\/02841869709001322 PubMed PMID: 9408150.","journal-title":"Acta Oncol"},{"key":"3803_CR231","doi-asserted-by":"publisher","unstructured":"Eke I, Zscheppang K, Dickreuter E, Hickmann L, Mazzeo E, Unger K, et al. Simultaneous \u03b21 integrin-EGFR targeting and radiosensitization of human head and neck cancer. J Natl Cancer Inst. 2015;107(2). https:\/\/doi.org\/10.1093\/jnci\/dju419.","DOI":"10.1093\/jnci\/dju419"},{"issue":"4","key":"3803_CR232","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1172\/JCI61350","volume":"122","author":"I Eke","year":"2012","unstructured":"Eke I, Deuse Y, Hehlgans S, Gurtner K, Krause M, Baumann M, et al. \u03b2\u2081Integrin\/FAK\/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J Clin Investig. 2012;122(4):1529\u201340. https:\/\/doi.org\/10.1172\/JCI61350.","journal-title":"J Clin Investig"},{"issue":"10","key":"3803_CR233","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/1541-7786.MCR-18-1352","volume":"17","author":"S Jin","year":"2019","unstructured":"Jin S, Lee WC, Aust D, Pilarsky C, Cordes N. \u03b28 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance. Mol cancer research: MCR. 2019;17(10):2126\u201338. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-1352.","journal-title":"Mol cancer research: MCR"},{"issue":"3","key":"3803_CR234","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1158\/0008-5472.CAN-05-3071","volume":"66","author":"CC Park","year":"2006","unstructured":"Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res. 2006;66(3):1526\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3071.","journal-title":"Cancer Res"},{"issue":"19","key":"3803_CR235","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/0008-5472.CAN-13-0344","volume":"73","author":"I Eke","year":"2013","unstructured":"Eke I, Storch K, Krause M, Cordes N. Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis. Cancer Res. 2013;73(19):5869\u201379. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0344.","journal-title":"Cancer Res"},{"key":"3803_CR236","doi-asserted-by":"publisher","unstructured":"Borodins O, Broghammer F, Seifert M, Cordes N. Meta-analysis of expression and the targeting of cell adhesion associated genes in nine cancer types \u2013 A one research lab re-evaluation. Comput Struct Biotechnol J. 2023;21. https:\/\/doi.org\/10.1016\/j.csbj.2023.04.017.","DOI":"10.1016\/j.csbj.2023.04.017"},{"issue":"4","key":"3803_CR237","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"L Seguin","year":"2015","unstructured":"Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25(4):234\u201340. https:\/\/doi.org\/10.1016\/j.tcb.2014.12.006.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"3803_CR238","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pros.20316","volume":"66","author":"CL Kremer","year":"2006","unstructured":"Kremer CL, Schmelz M, Cress AE. Integrin-dependent amplification of the G2 arrest induced by ionizing radiation. Prostate. 2006;66(1):88\u201396.","journal-title":"Prostate"},{"issue":"1","key":"3803_CR239","doi-asserted-by":"publisher","first-page":"e20181184","DOI":"10.1084\/jem.20181184","volume":"217","author":"A Haeger","year":"2020","unstructured":"Haeger A, Alexander S, Vullings M, Kaiser FMP, Veelken C, Flucke U, et al. Collective cancer invasion forms an integrin-dependent radioresistant niche. J Exp Med. 2020;217(1):e20181184. https:\/\/doi.org\/10.1084\/jem.20181184 . PubMed PMID: 31658985; PubMed Central PMCID: PMC7037234.","journal-title":"J Exp Med"},{"issue":"12","key":"3803_CR240","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1158\/2767-9764.CRC-23-0298","volume":"3","author":"W Echavidre","year":"2023","unstructured":"Echavidre W, Durivault J, Gotorbe C, Blanchard T, Pagnuzzi M, Vial V, et al. Integrin-\u03b1v\u03b23 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance. Cancer Res Commun. 2023;3(12):2483\u201396. https:\/\/doi.org\/10.1158\/2767-9764.CRC-23-0298 . PubMed PMID: 38009896; PubMed Central PMCID: PMC10702273.","journal-title":"Cancer Res Commun"},{"issue":"8","key":"3803_CR241","doi-asserted-by":"publisher","first-page":"116018","DOI":"10.1016\/j.celrep.2025.116018","volume":"44","author":"R Zhang","year":"2025","unstructured":"Zhang R, Yan W, Yuan J, Ma Y, Ren Z, Chen X, et al. Cancer-associated fibroblast-derived fibulin-5 promotes radioresistance in non-small-cell lung cancer. Cell Rep. 2025;44(8):116018. https:\/\/doi.org\/10.1016\/j.celrep.2025.116018 . PubMed PMID: 40711881.","journal-title":"Cell Rep"},{"issue":"5","key":"3803_CR242","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12032-015-0595-x","volume":"32","author":"X Jiang","year":"2015","unstructured":"Jiang X, Wang J, Zhang K, Tang S, Ren C, Chen Y. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells. Med Oncol. 2015;32(5):141. https:\/\/doi.org\/10.1007\/s12032-015-0595-x . PubMed PMID: 25805567.","journal-title":"Med Oncol"},{"issue":"10","key":"3803_CR243","doi-asserted-by":"publisher","first-page":"113270","DOI":"10.1016\/j.celrep.2023.113270","volume":"42","author":"X Yang","year":"2023","unstructured":"Yang X, Chen X, Zhang S, Fan W, Zhong C, Liu T, et al. Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer. Cell Rep. 2023;42(10):113270. https:\/\/doi.org\/10.1016\/j.celrep.2023.113270 . PubMed PMID: 37851572.","journal-title":"Cell Rep"},{"issue":"4","key":"3803_CR244","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10388-025-01147-2","volume":"22","author":"C Tang","year":"2025","unstructured":"Tang C, Zabihula B, Lu Y. HEYL-mediated activation of LAMA3 influences radiotherapy response in esophageal cancer. Esophagus. 2025;22(4):641\u201356. https:\/\/doi.org\/10.1007\/s10388-025-01147-2 . PubMed PMID: 40833662.","journal-title":"Esophagus"},{"issue":"30","key":"3803_CR245","doi-asserted-by":"publisher","first-page":"49224","DOI":"10.18632\/oncotarget.17480","volume":"8","author":"A Vehlow","year":"2017","unstructured":"Vehlow A, Klapproth E, Storch K, Dickreuter E, Seifert M, Dietrich A, et al. Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by \u03b21 integrin\/JNK co-targeting. Oncotarget. 2017;8(30):49224\u201337. https:\/\/doi.org\/10.18632\/oncotarget.17480.","journal-title":"Oncotarget"},{"key":"3803_CR246","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-662-49651-0","volume":"198","author":"A Vehlow","year":"2016","unstructured":"Vehlow A, Storch K, Matzke D, Cordes N. Mol Radio-Oncology Vol. 2016;198:198:89\u2013106. https:\/\/doi.org\/10.1007\/978-3-662-49651-0.","journal-title":"Mol Radio-Oncology Vol"},{"issue":"2","key":"3803_CR247","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbcan.2013.07.001","volume":"1836","author":"A Vehlow","year":"2013","unstructured":"Vehlow A, Cordes N. Invasion as target for therapy of glioblastoma multiforme. Biochim Biophys Acta. 2013;1836(2):236\u201344. https:\/\/doi.org\/10.1016\/j.bbcan.2013.07.001.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3803_CR248","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/neuonc\/noac237","volume":"25","author":"I Korovina","year":"2023","unstructured":"Korovina I, Vehlow A, Temme A, Cordes N. Targeting integrin \u03b12 as potential strategy for radiochemosensitization of glioblastoma. Neurooncology. 2023;25(4):648\u201361. https:\/\/doi.org\/10.1093\/neuonc\/noac237.","journal-title":"Neurooncology"},{"key":"3803_CR249","doi-asserted-by":"publisher","unstructured":"Moritz S, Krause M, Schlatter J, Cordes N, Vehlow A. Lamellipodin-rictor signaling mediates glioblastoma cell invasion and radiosensitivity downstream of egfr. Cancers. 2021;13(21). https:\/\/doi.org\/10.3390\/cancers13215337.","DOI":"10.3390\/cancers13215337"},{"issue":"2","key":"3803_CR250","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.canlet.2014.12.009","volume":"357","author":"A Steglich","year":"2015","unstructured":"Steglich A, Vehlow A, Eke I, Cordes N. \u03b1 integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells. Cancer Lett. 2015;357(2):542\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2014.12.009.","journal-title":"Cancer Lett"},{"issue":"26","key":"3803_CR251","doi-asserted-by":"publisher","first-page":"18099","DOI":"10.18632\/oncotarget.24266","volume":"9","author":"E Klapproth","year":"2018","unstructured":"Klapproth E, Dickreuter E, Zakrzewski F, Seifert M, Petzold A, Dahl A, et al. Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and \u03b21 integrin inhibition. Oncotarget. 2018;9(26):18099\u2013114. https:\/\/doi.org\/10.18632\/oncotarget.24266.","journal-title":"Oncotarget"},{"issue":"4","key":"3803_CR252","doi-asserted-by":"publisher","first-page":"e34279","DOI":"10.1371\/journal.pone.0034279","volume":"7","author":"O Zschenker","year":"2012","unstructured":"Zschenker O, Streichert T, Hehlgans S, Cordes N. Genome-wide gene expression analysis in cancer cells reveals 3D growth to affect ECM and processes associated with cell adhesion but not DNA repair. PLoS ONE. 2012;7(4):e34279\u201334279. https:\/\/doi.org\/10.1371\/journal.pone.0034279.","journal-title":"PLoS ONE"},{"issue":"13","key":"3803_CR253","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-09-2319","volume":"70","author":"JM Nam","year":"2011","unstructured":"Nam JM, Onodera Y, Bissell MJ, Park CC. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res. 2011;70(13):5238\u201348.","journal-title":"Cancer Res"},{"key":"3803_CR254","doi-asserted-by":"publisher","unstructured":"Broghammer F, Korovina I, Gouda M, Celotti M, van Es J, Lange I, et al. Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome. Mol Cancer. 2024;23(1). https:\/\/doi.org\/10.1186\/s12943-024-01954-8.","DOI":"10.1186\/s12943-024-01954-8"},{"issue":"4","key":"3803_CR255","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1083\/jcb.138.4.901","volume":"138","author":"G McGill","year":"1997","unstructured":"McGill G, Shimamura A, Bates RC, Savage RE, Fisher DE. Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol. 1997;138(4):901\u201311. https:\/\/doi.org\/10.1083\/jcb.138.4.901 . PubMed PMID: 9265655; PubMed Central PMCID: PMC2138041.","journal-title":"J Cell Biol"},{"issue":"11\u201312","key":"3803_CR256","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/09553000701633135","volume":"83","author":"SC Pawar","year":"2007","unstructured":"Pawar SC, Dougherty S, Pennington ME, Demetriou MC, Stea BD, Dorr RT, et al. alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation. Int J Radiat Biol. 2007;83(11\u201312):761\u20137.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"3803_CR257","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/1078-0432.CCR-23-0964","volume":"30","author":"PM Pifer","year":"2024","unstructured":"Pifer PM, Yang L, Kumar M, Xie T, Frederick M, Hefner A, et al. FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner. Clin Cancer Res. 2024;30(1):187\u201397. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0964 . PubMed PMID: 37819945; PubMed Central PMCID: PMC10767302.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3803_CR258","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/ndt\/gfp525","volume":"25","author":"L Krasny","year":"2010","unstructured":"Krasny L, Shimony N, Tzukert K, Gorodetsky R, Lecht S, Nettelbeck DM, et al. An in-vitro tumour microenvironment model using adhesion to type I collagen reveals Akt-dependent radiation resistance in renal cancer cells. Nephrol Dial Transpl. 2010;25(2):373\u201380. https:\/\/doi.org\/10.1093\/ndt\/gfp525 . PubMed PMID: 19828461.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"3803_CR259","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2015.04.019","volume":"364","author":"E Zienert","year":"2015","unstructured":"Zienert E, Eke I, Aust D, Cordes N. LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells. Cancer Lett. 2015;364(1):17\u201324. https:\/\/doi.org\/10.1016\/j.canlet.2015.04.019.","journal-title":"Cancer Lett"},{"issue":"57","key":"3803_CR260","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1038\/sj.onc.1205939","volume":"21","author":"AC Kraus","year":"2002","unstructured":"Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, et al. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene. 2002;21(57):8683\u201395. https:\/\/doi.org\/10.1038\/sj.onc.1205939 . PubMed PMID: 12483521.","journal-title":"Oncogene"},{"issue":"16","key":"3803_CR261","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1158\/0008-5472.CAN-04-1056","volume":"64","author":"N Cordes","year":"2004","unstructured":"Cordes N. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cancer Res. 2004;64(16):5683\u201392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1056.","journal-title":"Cancer Res"},{"key":"3803_CR262","doi-asserted-by":"publisher","unstructured":"Cordes N, Hansmeier B, Beinke C, Meineke V, Van Beuningen D. Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines. Br J Cancer. 2003;89(11). https:\/\/doi.org\/10.1038\/sj.bjc.6601429.","DOI":"10.1038\/sj.bjc.6601429"},{"issue":"9","key":"3803_CR263","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/sj.onc.1209164","volume":"25","author":"N Cordes","year":"2006","unstructured":"Cordes N, Seidler J, Durzok R, Geinitz H, Brakebusch C. beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene. 2006;25(9):1378\u201390.","journal-title":"Oncogene"},{"issue":"2","key":"3803_CR264","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41418-018-0114-7","volume":"26","author":"SH Jung","year":"2019","unstructured":"Jung SH, Lee M, Park HA, Lee HC, Kang D, Hwang HJ, et al. Integrin \u03b16\u03b24-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues. Cell Death Differ. 2019;26(2):245\u201359. https:\/\/doi.org\/10.1038\/s41418-018-0114-7 . PubMed PMID: 29786073; PubMed Central PMCID: PMC6329762.","journal-title":"Cell Death Differ"},{"issue":"4","key":"3803_CR265","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1016\/j.ijrobp.2011.09","volume":"82","author":"J Ou","year":"2012","unstructured":"Ou J, Pan F, Geng P, Wei X, Xie G, Deng J, et al. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK\/Akt\/JNK pathway. Int J Radiat Oncol Biol Phys. 2012;82(4):e685\u2013691. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09. .040 PubMed PMID: 22208970.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"3803_CR266","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/s41588-025-02253-8","volume":"57","author":"R You","year":"2025","unstructured":"You R, Shen Q, Lin C, Dong K, Liu X, Xu H, et al. Single-cell and spatial transcriptomics reveal mechanisms of radioresistance and immune escape in recurrent nasopharyngeal carcinoma. Nat Genet. 2025;57(8):1950\u201365. https:\/\/doi.org\/10.1038\/s41588-025-02253-8 . PubMed PMID: 40691404.","journal-title":"Nat Genet"},{"issue":"2","key":"3803_CR267","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/stem.1843","volume":"33","author":"KE Williams","year":"2015","unstructured":"Williams KE, Bundred NJ, Landberg G, Clarke RB, Farnie G. Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy. Stem Cells. 2015;33(2):327\u201341. https:\/\/doi.org\/10.1002\/stem.1843 . PubMed PMID: 25187396.","journal-title":"Stem Cells"},{"issue":"8","key":"3803_CR268","doi-asserted-by":"publisher","first-page":"679","DOI":"10.18632\/oncoscience.184","volume":"2","author":"E Dickreuter","year":"2015","unstructured":"Dickreuter E, Cordes N. Cell-ECM interactions control DDR. Oncoscience. 2015;2(8):679\u201380. https:\/\/doi.org\/10.18632\/oncoscience.184 . PubMed PMID: 26425656; PubMed Central PMCID: PMC4580058.","journal-title":"Oncoscience"},{"key":"3803_CR269","doi-asserted-by":"publisher","first-page":"215855","DOI":"10.1016\/j.canlet.2022.215855","volume":"547","author":"C Zhou","year":"2022","unstructured":"Zhou C, Li S, Bin K, Qin G, Pan P, Ren D, et al. ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. Cancer Lett. 2022;547:215855. https:\/\/doi.org\/10.1016\/j.canlet.2022.215855 . PubMed PMID: 35998796.","journal-title":"Cancer Lett"},{"issue":"10","key":"3803_CR270","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/sj.cdd.4401849","volume":"13","author":"PS Hodkinson","year":"2006","unstructured":"Hodkinson PS, Elliott T, Wong WS, Rintoul RC, Mackinnon AC, Haslett C, et al. ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase. Cell Death Differ. 2006;13(10):1776\u201388. https:\/\/doi.org\/10.1038\/sj.cdd.4401849 . PubMed PMID: 16410797.","journal-title":"Cell Death Differ"},{"issue":"3","key":"3803_CR271","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jmb","volume":"337","author":"S Monferran","year":"2004","unstructured":"Monferran S, Muller C, Mourey L, Frit P, Salles B. The Membrane-associated form of the DNA repair protein Ku is involved in cell adhesion to fibronectin. J Mol Biol. 2004;337(3):503\u201311. https:\/\/doi.org\/10.1016\/j.jmb. 2004.01.057 PubMed PMID: 15019772.","journal-title":"J Mol Biol"},{"key":"3803_CR272","doi-asserted-by":"publisher","first-page":"33376","DOI":"10.1038\/srep33376","volume":"6","author":"T Hu","year":"2016","unstructured":"Hu T, Zhou R, Zhao Y, Wu G. Integrin \u03b16\/Akt\/Erk signaling is essential for human breast cancer resistance to radiotherapy. Sci Rep. 2016;6:33376. https:\/\/doi.org\/10.1038\/srep33376 . PubMed PMID: 27624978; PubMed Central PMCID: PMC5022055.","journal-title":"Sci Rep"},{"issue":"12","key":"3803_CR273","doi-asserted-by":"publisher","first-page":"e27806","DOI":"10.1371\/journal.pone.0027806","volume":"6","author":"K Graham","year":"2011","unstructured":"Graham K, Moran-Jones K, Sansom OJ, Brunton VG, Frame MC. FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells. PLoS ONE. 2011;6(12):e27806. https:\/\/doi.org\/10.1371\/journal.pone.0027806 . PubMed PMID: 22194793; PubMed Central PMCID: PMC3237418.","journal-title":"PLoS ONE"},{"issue":"2","key":"3803_CR274","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/1541-7786.MCR-18-0544","volume":"17","author":"T Wang","year":"2019","unstructured":"Wang T, Huang J, Vue M, Alavian MR, Goel HL, Altieri DC, et al. \u03b1v\u03b23 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin. Mol cancer research: MCR. 2019;17(2):398\u2013408. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0544.","journal-title":"Mol cancer research: MCR"},{"issue":"17","key":"3803_CR275","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1158\/0008-5472.CAN-16-0543","volume":"76","author":"H Lu","year":"2016","unstructured":"Lu H, Wang T, Li J, Fedele C, Liu Q, Zhang J, et al. \u03b1v\u03b26 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor. Cancer Res. 2016;76(17):5163\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0543 . PubMed PMID: 27450452; PubMed Central PMCID: PMC5012867.","journal-title":"Cancer Res"},{"key":"3803_CR276","doi-asserted-by":"publisher","first-page":"887068","DOI":"10.3389\/fonc.2022.887068","volume":"12","author":"X Wen","year":"2022","unstructured":"Wen X, Chen S, Chen X, Qiu H, Wang W, Zhang N, et al. ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK\/ERK signaling pathway. Front Oncol. 2022;12:887068. https:\/\/doi.org\/10.3389\/fonc.2022.887068 . PubMed PMID: 36249018; PubMed Central PMCID: PMC9563233.","journal-title":"Front Oncol"},{"issue":"8","key":"3803_CR277","doi-asserted-by":"publisher","first-page":"e70905","DOI":"10.1371\/journal.pone.0070905","volume":"8","author":"X Li","year":"2013","unstructured":"Li X, Ishihara S, Yasuda M, Nishioka T, Mizutani T, Ishikawa M, et al. Lung cancer cells that survive ionizing radiation show increased integrin \u03b12\u03b21- and EGFR-dependent invasiveness. PLoS ONE. 2013;8(8):e70905. https:\/\/doi.org\/10.1371\/journal.pone.0070905 . PubMed PMID: 23951036; PubMed Central PMCID: PMC3738636.","journal-title":"PLoS ONE"},{"issue":"1","key":"3803_CR278","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/jpet.106.113498","volume":"321","author":"JL Rose","year":"2007","unstructured":"Rose JL, Reeves KC, Likhotvorik RI, Hoyt DG. Base excision repair proteins are required for integrin-mediated suppression of bleomycin-induced DNA breakage in murine lung endothelial cells. J Pharmacol Exp Ther. 2007;321(1):318\u201326. https:\/\/doi.org\/10.1124\/jpet.106.113498 . PubMed PMID: 17202402.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"3803_CR279","doi-asserted-by":"publisher","first-page":"e00672","DOI":"10.1128\/MCB.00672-17","volume":"38","author":"KM Ahmed","year":"2018","unstructured":"Ahmed KM, Pandita RK, Singh DK, Hunt CR, Pandita TK. \u03b21-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination. Mol Cell Biol. 2018;38(9):e00672\u201317. https:\/\/doi.org\/10.1128\/MCB.00672-17 . PubMed PMID: 29463647; PubMed Central PMCID: PMC5902589.","journal-title":"Mol Cell Biol"},{"issue":"17","key":"3803_CR280","doi-asserted-by":"publisher","first-page":"27754","DOI":"10.18632\/oncotarget.10897","volume":"8","author":"M Christmann","year":"2017","unstructured":"Christmann M, Diesler K, Majhen D, Steigerwald C, Berte N, Freund H, et al. Integrin \u03b1V\u03b23 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair. Oncotarget. 2017;8(17):27754\u201371. https:\/\/doi.org\/10.18632\/oncotarget.10897 . PubMed PMID: 27487141; PubMed Central PMCID: PMC5438606.","journal-title":"Oncotarget"},{"key":"3803_CR281","doi-asserted-by":"publisher","first-page":"1043538","DOI":"10.3389\/fonc.2022.1043538","volume":"12","author":"M Chen","year":"2022","unstructured":"Chen M, Marrs B, Qi L, Knifley T, Weiss HL, D\u2019Orazio JA, et al. Integrin \u03b16\u03b24 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin. Front Oncol. 2022;12:1043538. https:\/\/doi.org\/10.3389\/fonc.2022.1043538 . PubMed PMID: 36439467; PubMed Central PMCID: PMC9686853.","journal-title":"Front Oncol"},{"key":"3803_CR282","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.matbio.2024.04","volume":"130","author":"SM Haake","year":"2024","unstructured":"Haake SM, Rios BL, Pozzi A, Zent R. Integrating integrins with the hallmarks of cancer. Matrix Biol. 2024;130:20\u201335. https:\/\/doi.org\/10.1016\/j.matbio.2024.04. .003 PubMed PMID: 38677444.","journal-title":"Matrix Biol"},{"key":"3803_CR283","doi-asserted-by":"publisher","first-page":"154","DOI":"10.7150\/thno\/v01p0154","volume":"1","author":"M Millard","year":"2011","unstructured":"Millard M, Odde S, Neamati N. Integrin targeted therapeutics. Theranostics. 2011;1:154\u201388.","journal-title":"Theranostics"},{"issue":"23","key":"3803_CR284","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2174\/138161211797249189","volume":"17","author":"G Tabatabai","year":"2011","unstructured":"Tabatabai G, Tonn JC, Stupp R, Weller M. The role of integrins in glioma biology and anti-glioma therapies. Curr Pharm Design. 2011;17(23):2402\u201310.","journal-title":"Curr Pharm Design"},{"issue":"12","key":"3803_CR285","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-12-3537","volume":"73","author":"KM Ahmed","year":"2013","unstructured":"Ahmed KM, Zhang H, Park CC. NF-\u03baB regulates radioresistance mediated by \u03b21-integrin in three-dimensional culture of breast cancer cells. Cancer Res. 2013;73(12):3737\u201348. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3537 . PubMed PMID: 23576567; PubMed Central PMCID: PMC3698967.","journal-title":"Cancer Res"},{"key":"3803_CR286","doi-asserted-by":"publisher","first-page":"116217","DOI":"10.1016\/j.biopha.2024.116217","volume":"171","author":"I Korovina","year":"2024","unstructured":"Korovina I, Elser M, Borodins O, Seifert M, Willers H, Cordes N. \u03b21 integrin mediates unresponsiveness to PI3K\u03b1 inhibition for radiochemosensitization of 3D HNSCC models. Biomed Pharmacother. 2024;171:116217. https:\/\/doi.org\/10.1016\/j.biopha.2024.116217 . PubMed PMID: 38286037; PubMed Central PMCID: PMC11627550.","journal-title":"Biomed Pharmacother"},{"key":"3803_CR287","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24240","author":"T Mikkelsen","year":"2009","unstructured":"Mikkelsen T, Brodie C, Finniss S, Berens ME, Rennert JL, Nelson K, et al. Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency. Int J cancer J Int du cancer. 2009. https:\/\/doi.org\/10.1002\/ijc.24240.","journal-title":"Int J cancer J Int du cancer"},{"issue":"3","key":"3803_CR288","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ijrobp.2008.11.050","volume":"75","author":"C Massabeau","year":"2009","unstructured":"Massabeau C, Rouquette I, Lauwers-Cances V, Mazi\u00e8res J, Bachaud JM, Armand JP, et al. Basic fibroblast growth factor-2\/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;75(3):696\u2013702. .050 PubMed PMID: 19386436.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3803_CR289","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ijc.23498","volume":"123","author":"S Monferran","year":"2008","unstructured":"Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, Cohen-Jonathan-Moyal E, et al. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer. 2008;123(2):357\u201364. https:\/\/doi.org\/10.1002\/ijc.23498 . PubMed PMID: 18464290.","journal-title":"Int J Cancer"},{"issue":"10","key":"3803_CR290","first-page":"4597","volume":"13","author":"M Elser","year":"2023","unstructured":"Elser M, Vehlow A, Juratli TA, Cordes N. Simultaneous inhibition of discoidin domain receptor 1 and integrin \u03b1V\u03b23 radiosensitizes human glioblastoma cells. Am J Cancer Res. 2023;13(10):4597\u2013612. PubMed PMID: 37970361; PubMed Central PMCID: PMC10636682.","journal-title":"Am J Cancer Res"},{"issue":"10","key":"3803_CR291","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","volume":"15","author":"R Stupp","year":"2014","unstructured":"Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071\u2009\u2013\u200922072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15(10):1100\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(14)70379-1.","journal-title":"Lancet Oncol"},{"issue":"16","key":"3803_CR292","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1200\/JCO.2009.26.6650","volume":"28","author":"R Stupp","year":"2010","unstructured":"Stupp R, Hegi ME, Neyns B, Goldbrunner R, Schlegel U, Clement PM, et al. Phase I\/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. J Clin Oncol. 2010;28(16):2712\u20138.","journal-title":"J Clin Oncol"},{"issue":"12","key":"3803_CR293","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1093\/annonc\/mdw427","volume":"27","author":"JC Soria","year":"2016","unstructured":"Soria JC, Gan HK, Blagden SP, Plummer R, Arkenau HT, Ranson M, et al. A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors. Ann Oncol. 2016;27(12):2268\u201374. https:\/\/doi.org\/10.1093\/annonc\/mdw427 . PubMed PMID: 27733373.","journal-title":"Ann Oncol"},{"key":"3803_CR294","doi-asserted-by":"publisher","first-page":"e2400327","DOI":"10.1200\/PO.24.00327","volume":"8","author":"MG Zauderer","year":"2024","unstructured":"Zauderer MG, Jegede O, Jackman DM, Zwiebel JA, Gray RJ, Wang V, et al. Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024;8:e2400327. https:\/\/doi.org\/10.1200\/PO.24.00327 . PubMed PMID: 39693587; PubMed Central PMCID: PMC11803527.","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"3803_CR295","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 2020;18(1):59. https:\/\/doi.org\/10.1186\/s12964-020-0530-4 . PubMed PMID: 32264958; PubMed Central PMCID: PMC7140346.","journal-title":"Cell Commun Signal"},{"key":"3803_CR296","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014","volume":"30","author":"H Bolouri","year":"2015","unstructured":"Bolouri H. Network dynamics in the tumor microenvironment. Semin Cancer Biol. 2015;30:52\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2014. 02.007 PubMed PMID: 24582766.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3803_CR297","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12672-023-00828-7","volume":"14","author":"B Yan","year":"2023","unstructured":"Yan B, Liao P, Shi L, Lei P. Pan-cancer analyses of senescence-related genes in extracellular matrix characterization in cancer. Discov Oncol. 2023;14(1):208. https:\/\/doi.org\/10.1007\/s12672-023-00828-7 . PubMed PMID: 37985530; PubMed Central PMCID: PMC10660488.","journal-title":"Discov Oncol"},{"issue":"11","key":"3803_CR298","first-page":"12386","volume":"13","author":"PJ Vlachostergios","year":"2021","unstructured":"Vlachostergios PJ. Integrin signaling gene alterations and outcomes of cancer patients receiving immune checkpoint inhibitors. Am J Transl Res. 2021;13(11):12386\u201394. PubMed PMID: 34956460; PubMed Central PMCID: PMC8661141.","journal-title":"Am J Transl Res"},{"key":"3803_CR299","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.regen.2018.03.002","volume":"1","author":"AS Barrett","year":"2018","unstructured":"Barrett AS, Maller O, Pickup MW, Weaver VM, Hansen KC. Compartment resolved proteomics reveals a dynamic matrisome in a biomechanically driven model of pancreatic ductal adenocarcinoma. J Immunol Regen Med. 2018;1:67\u201375. https:\/\/doi.org\/10.1016\/j.regen.2018.03.002 . PubMed PMID: 36908331; PubMed Central PMCID: PMC10003644.","journal-title":"J Immunol Regen Med"},{"key":"3803_CR300","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41698-019-0087-0","volume":"3","author":"S Bin Lim","year":"2019","unstructured":"Bin Lim S, Chua MLK, Yeong JPS, Tan SJ, Lim WT, Lim CT. Pan-cancer analysis connects tumor matrisome to immune response. NPJ Precis Oncol. 2019;3:15. https:\/\/doi.org\/10.1038\/s41698-019-0087-0 . PubMed PMID: 31123708; PubMed Central PMCID: PMC6531473.","journal-title":"NPJ Precis Oncol"},{"key":"3803_CR301","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.matbio.2022.06.003","volume":"111","author":"TV Tellman","year":"2022","unstructured":"Tellman TV, Dede M, Aggarwal VA, Salmon D, Naba A, Farach-Carson MC. Systematic Analysis of Actively Transcribed Core Matrisome Genes Across Tissues and Cell Phenotypes. Matrix Biol. 2022;111:95\u2013107. https:\/\/doi.org\/10.1016\/j.matbio.2022.06.003 . PubMed PMID: 35714875.","journal-title":"Matrix Biol"},{"issue":"6","key":"3803_CR302","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1002\/ar.24086","volume":"303","author":"SR Lamand\u00e9","year":"2020","unstructured":"Lamand\u00e9 SR, Bateman JF. Genetic Disorders of the Extracellular Matrix. Anat Rec (Hoboken). 2020;303(6):1527\u201342. 10. 1002\/ar.24086 PubMed PMID: 30768852; PubMed Central PMCID: PMC7318566.","journal-title":"Anat Rec (Hoboken)"},{"issue":"4","key":"3803_CR303","doi-asserted-by":"publisher","first-page":"qzae035","DOI":"10.1093\/gpbjnl\/qzae035","volume":"22","author":"C Zou","year":"2024","unstructured":"Zou C, Zhu J, Xiong J, Tian Y, Peng Y, Cheung E, et al. Comprehensive Characterization of the Integrin Family Across 32 Cancer Types. Genomics Proteom Bioinf. 2024;22(4):qzae035. https:\/\/doi.org\/10.1093\/gpbjnl\/qzae035 . PubMed PMID: 39436262; PubMed Central PMCID: PMC11849494.","journal-title":"Genomics Proteom Bioinf"},{"key":"3803_CR304","doi-asserted-by":"publisher","unstructured":"Sato T, Vries RG, Snippert HJ, Van De Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244). https:\/\/doi.org\/10.1038\/nature07935.","DOI":"10.1038\/nature07935"},{"issue":"7467","key":"3803_CR305","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346\u201354. https:\/\/doi.org\/10.1038\/nature12626 . PubMed PMID: 24048067.","journal-title":"Nature"},{"issue":"5","key":"3803_CR306","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350. https:\/\/doi.org\/10.1038\/s41591-018-0014-x . PubMed PMID: 29686425; PubMed Central PMCID: PMC5998822.","journal-title":"Nat Med"},{"key":"3803_CR307","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.biomaterials","volume":"145","author":"C Ringuette Goulet","year":"2017","unstructured":"Ringuette Goulet C, Bernard G, Chabaud S, Couture A, Langlois A, Neveu B, et al. Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery. Biomaterials. 2017;145:233\u201341. https:\/\/doi.org\/10.1016\/j.biomaterials. .2017.08.041 PubMed PMID: 28888113.","journal-title":"Biomaterials"},{"key":"3803_CR308","doi-asserted-by":"publisher","first-page":"6051210","DOI":"10.1155\/2020\/6051210","volume":"2020","author":"V Roy","year":"2020","unstructured":"Roy V, Magne B, Vaillancourt-Audet M, Blais M, Chabaud S, Grammond E, et al. Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors. Biomed Res Int. 2020;2020:6051210. https:\/\/doi.org\/10.1155\/2020\/6051210 . PubMed PMID: 32352002; PubMed Central PMCID: PMC7178531.","journal-title":"Biomed Res Int"},{"key":"3803_CR309","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41698-020-0121-2","volume":"4","author":"P Datta","year":"2020","unstructured":"Datta P, Dey M, Ataie Z, Unutmaz D, Ozbolat IT. 3D bioprinting for reconstituting the cancer microenvironment. NPJ Precis Oncol. 2020;4:18. https:\/\/doi.org\/10.1038\/s41698-020-0121-2 . PubMed PMID: 32793806; PubMed Central PMCID: PMC7385083.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"3803_CR310","doi-asserted-by":"publisher","first-page":"012003","DOI":"10.1088\/1758-5090\/ad0b3f","volume":"16","author":"M Yeo","year":"2023","unstructured":"Yeo M, Sarkar A, Singh YP, Derman ID, Datta P, Ozbolat IT. Synergistic coupling between 3D bioprinting and vascularization strategies. Biofabrication. 2023;16(1):012003. https:\/\/doi.org\/10.1088\/1758-5090\/ad0b3f . PubMed PMID: 37944186; PubMed Central PMCID: PMC10658349.","journal-title":"Biofabrication"},{"issue":"12","key":"3803_CR311","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41568-022","volume":"22","author":"L Neufeld","year":"2022","unstructured":"Neufeld L, Yeini E, Pozzi S, Satchi-Fainaro R. 3D bioprinted cancer models: from basic biology to drug development. Nat Rev Cancer. 2022;22(12):679\u201392. https:\/\/doi.org\/10.1038\/s41568-022-. 00514-w PubMed PMID: 36280768.","journal-title":"Nat Rev Cancer"},{"key":"3803_CR312","doi-asserted-by":"publisher","first-page":"102633","DOI":"10.1016\/j.tranon.2025.102633","volume":"63","author":"M Edwards","year":"2026","unstructured":"Edwards M, Caruana P, Escar M, C\u00e9spedes MV. Shaping the future one slice at a time: How 3D organotypic tumour slice models are driving drug discovery in ovarian cancer. Transl Oncol. 2026;63:102633. https:\/\/doi.org\/10.1016\/j.tranon.2025.102633 . PubMed PMID: 41351993; PubMed Central PMCID: PMC12731798.","journal-title":"Transl Oncol"},{"key":"3803_CR313","doi-asserted-by":"publisher","first-page":"204173142413080","DOI":"10.1177\/20417314241308022","volume":"16","author":"V Mathur","year":"2025","unstructured":"Mathur V, Agarwal P, Kasturi M, Srinivasan V, Seetharam RN, Vasanthan KS. Innovative bioinks for 3D bioprinting: Exploring technological potential and regulatory challenges. J Tissue Eng. 2025;16:20417314241308022. doi:10.1177\/20417314241308022 PubMed PMID: 39839985; PubMed Central PMCID: PMC11748162.","journal-title":"J Tissue Eng"},{"issue":"19","key":"3803_CR314","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1021\/acs.chemrev.9b00812","volume":"120","author":"KS Lim","year":"2020","unstructured":"Lim KS, Galarraga JH, Cui X, Lindberg GCJ, Burdick JA, Woodfield TBF. Fundamentals and Applications of Photo-Cross-Linking in Bioprinting. Chem Rev. 2020;120(19):10662\u201394. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00812 . PubMed PMID: 32302091.","journal-title":"Chem Rev"},{"issue":"9","key":"3803_CR315","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4(9):998\u20131013. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0001 . PubMed PMID: 25185190; PubMed Central PMCID: PMC4167608.","journal-title":"Cancer Discov"},{"key":"3803_CR316","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2748","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010. https:\/\/doi.org\/10.1038\/nrc2748.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3803_CR317","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/s0959-8049(03)00057-1","volume":"39","author":"Fa Eskens","year":"2003","unstructured":"Eskens Fa, Dumez LM, Hoekstra H, Perschl R, Brindley A, B\u00f6ttcher C. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours. Eur J Cancer. 2003;39(7):917\u201326. https:\/\/doi.org\/10.1016\/s0959-8049(03)00057-1 . PubMed PMID: 12706360.","journal-title":"Eur J Cancer"},{"issue":"7","key":"3803_CR318","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1158\/1078-0432.CCR-06-2779","volume":"13","author":"SA Mullamitha","year":"2007","unstructured":"Mullamitha SA, Ton NC, Parker GJM, Jackson A, Julyan PJ, Roberts C, et al. Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin Cancer Res. 2007;13(7):2128\u201335. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2779 . PubMed PMID: 17404096.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3803_CR319","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1208\/s12248-011-9260-2","volume":"13","author":"RJ Keizer","year":"2011","unstructured":"Keizer RJ, Funahashi Y, Semba T, Wanders J, Beijnen JH, Schellens JHM, et al. Evaluation of \u03b12-integrin expression as a biomarker for tumor growth inhibition for the investigational integrin inhibitor E7820 in preclinical and clinical studies. AAPS J. 2011;13(2):230\u20139. https:\/\/doi.org\/10.1208\/s12248-011-9260-2 . PubMed PMID: 21387147; PubMed Central PMCID: PMC3085714.","journal-title":"AAPS J"},{"issue":"3","key":"3803_CR320","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/annonc\/mdu003","volume":"25","author":"JB Vermorken","year":"2014","unstructured":"Vermorken JB, Peyrade F, Krauss J, Mes\u00eda R, Remenar E, Gauler TC, et al. Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent\/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I\/II ADVANTAGE trial (phase II part). Ann Oncol. 2014;25(3):682\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdu003 . PubMed PMID: 24567516; PubMed Central PMCID: PMC3933250.","journal-title":"Ann Oncol"},{"issue":"2","key":"3803_CR321","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10637-015-0320-9","volume":"34","author":"GA Cirkel","year":"2016","unstructured":"Cirkel GA, Kerklaan BM, Vanhoutte F, Van der Aa A, Lorenzon G, Namour F, et al. A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies. Invest New Drugs. 2016;34(2):184\u201392. https:\/\/doi.org\/10.1007\/s10637-015-0320-9 . PubMed PMID: 26792581; PubMed Central PMCID: PMC4786599.","journal-title":"Invest New Drugs"},{"issue":"3","key":"3803_CR322","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1200\/JCO.21.02371","volume":"41","author":"PK Brastianos","year":"2023","unstructured":"Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, et al. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. J Clin Oncol. 2023;41(3):618\u201328. https:\/\/doi.org\/10.1200\/JCO.21.02371 . PubMed PMID: 36288512; PubMed Central PMCID: PMC9870228.","journal-title":"J Clin Oncol"},{"key":"3803_CR323","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.lungcan.2019.10.033","volume":"139","author":"DE Gerber","year":"2020","unstructured":"Gerber DE, Camidge DR, Morgensztern D, Cetnar J, Kelly RJ, Ramalingam SS, et al. Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer. Lung Cancer. 2020;139:60\u20137. https:\/\/doi.org\/10.1016\/j.lungcan.2019.10.033 . PubMed PMID: 31739184; PubMed Central PMCID: PMC6942685.","journal-title":"Lung Cancer"},{"issue":"12","key":"3803_CR324","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/neuonc\/noy078","volume":"20","author":"NF Brown","year":"2018","unstructured":"Brown NF, Williams M, Arkenau HT, Fleming RA, Tolson J, Yan L, et al. A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11\u00a0C]GSK2256098. Neuro Oncol. 2018;20(12):1634\u201342. https:\/\/doi.org\/10.1093\/neuonc\/noy078 . PubMed PMID: 29788497; PubMed Central PMCID: PMC6231205.","journal-title":"Neuro Oncol"},{"issue":"1","key":"3803_CR325","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12967","volume":"18","author":"A Hauge","year":"2020","unstructured":"Hauge A, Rofstad EK. Antifibrotic therapy to normalize the tumor microenvironment. J Transl Med. 2020;18(1):207. https:\/\/doi.org\/10.1186\/s12967-. 020-02376-y PubMed PMID: 32434573; PubMed Central PMCID: PMC7240990.","journal-title":"J Transl Med"},{"issue":"7","key":"3803_CR326","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41568-025-00819-6","volume":"25","author":"MH Barcellos-Hoff","year":"2025","unstructured":"Barcellos-Hoff MH, Yom SS. Revisiting the TGF\u03b2 paradox: insights from HPV-driven cancer and the DNA damage response. Nat Rev Cancer. 2025;25(7):534\u201344. https:\/\/doi.org\/10.1038\/s41568-025-00819-6 . PubMed PMID: 40389543; PubMed Central PMCID: PMC12557705.","journal-title":"Nat Rev Cancer"},{"key":"3803_CR327","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2018.01","volume":"417","author":"KA Johnston","year":"2018","unstructured":"Johnston KA, Lopez KM. Lysyl oxidase in cancer inhibition and metastasis. Cancer Lett. 2018;417:174\u201381. https:\/\/doi.org\/10.1016\/j.canlet.2018.01. .006 PubMed PMID: 29309816.","journal-title":"Cancer Lett"},{"key":"3803_CR328","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.matbio.2023.12.003","volume":"125","author":"P Trono","year":"2024","unstructured":"Trono P, Ottavi F, Rosano\u2019 L. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention. Matrix Biol. 2024;125:31\u20139. https:\/\/doi.org\/10.1016\/j.matbio.2023.12.003 . PubMed PMID: 38081526.","journal-title":"Matrix Biol"},{"issue":"7931","key":"3803_CR329","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","volume":"610","author":"H Su","year":"2022","unstructured":"Su H, Yang F, Fu R, Trinh B, Sun N, Liu J, et al. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature. 2022;610(7931):366\u201372. https:\/\/doi.org\/10.1038\/s41586-022-05169-z . PubMed PMID: 36198801; PubMed Central PMCID: PMC9588640.","journal-title":"Nature"},{"issue":"5","key":"3803_CR330","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tcb","volume":"34","author":"H Su","year":"2024","unstructured":"Su H, Karin M. Multifaceted collagen-DDR1 signaling in cancer. Trends Cell Biol. 2024;34(5):406\u201315. https:\/\/doi.org\/10.1016\/j.tcb. .2023.08.003 PubMed PMID: 37709651; PubMed Central PMCID: PMC10927612.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"3803_CR331","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1 . PubMed PMID: 31980749; PubMed Central PMCID: PMC7046529.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3803_CR332","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105(4):256\u201365. https:\/\/doi.org\/10.1093\/jnci\/djs. 629 PubMed PMID: 23291374; PubMed Central PMCID: PMC3576324.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3803_CR333","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","volume":"8","author":"RW Jenkins","year":"2018","unstructured":"Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, et al. Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov. 2018;8(2):196\u2013215. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0833 . PubMed PMID: 29101162; PubMed Central PMCID: PMC5809290.","journal-title":"Cancer Discov"},{"issue":"3","key":"3803_CR334","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean MC, Validire P, Trautmann A, et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest. 2012;122(3):899\u2013910. 45817 PubMed PMID: 22293174; PubMed Central PMCID: PMC3287213.","journal-title":"J Clin Invest"},{"issue":"8","key":"3803_CR335","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nm.4123","volume":"22","author":"H Jiang","year":"2016","unstructured":"Jiang H, Hegde S, Knolhoff BL, Zhu Y, Herndon JM, Meyer MA, et al. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nat Med. 2016;22(8):851\u201360. https:\/\/doi.org\/10.1038\/nm.4123 . PubMed PMID: 27376576; PubMed Central PMCID: PMC4935930.","journal-title":"Nat Med"},{"key":"3803_CR336","doi-asserted-by":"publisher","unstructured":"Pepin KM, McGee KP. Quantifying tumor stiffness with magnetic resonance elastography the role of mechanical properties for detection, characterization, and treatment stratification in oncology. Top Magn Reson Imaging. 2018;27(5). https:\/\/doi.org\/10.1097\/RMR.0000000000000181.","DOI":"10.1097\/RMR.0000000000000181"},{"key":"3803_CR337","doi-asserted-by":"publisher","unstructured":"Fovargue D, Nordsletten D, Sinkus R. Stiffness reconstruction methods for MR elastography. NMR Biomed. 2018;31(10). https:\/\/doi.org\/10.1002\/nbm.3935.","DOI":"10.1002\/nbm.3935"},{"issue":"1","key":"3803_CR338","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10791","volume":"29","author":"JCL Chow","year":"2026","unstructured":"Chow JCL. Machine learning in cancer imaging for enhanced precision in diagnosis and therapy. Discov Comput. 2026;29(1):186. https:\/\/doi.org\/10.1007\/s10791-. 026-10078-0 PubMed PMID: 41924555; PubMed Central PMCID: PMC13035700.","journal-title":"Discov Comput"},{"key":"3803_CR339","doi-asserted-by":"publisher","unstructured":"Dupont J, Frau F, Robic V, Manso Jimeno M, Phan L, Nougaret S et al. Beyond handcrafted radiomics in oncologic imaging: Innovations in deep, explainable, multi-site and multi-omics radiomics approaches. Diagn Interv Imaging. 2026;S2211-5684(26)00026\u2009\u2013\u20094. https:\/\/doi.org\/10.1016\/j.diii.2026.02.001 PubMed PMID: 41690886.","DOI":"10.1016\/j.diii.2026.02"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03803-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:04:58Z","timestamp":1785909898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03803-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":339,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3803"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03803-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has approved to publish this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"170"}}